Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	HNF1B CUX2 TCF7L2 HIVEP1 HIVEP2 TCF12 CEBPA ESRRG ETV1 NR1D1 ATF2 ZEB2 HIVEP3 BCL11B ZFHX4 NFATC2 HEY1 SKOR2 NFYC MAFB MUC1 LEF1 EP300 CREB3L2 NOBOX FOXC2	1.93e-07	1244	134	26	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	HNF1B CUX2 TCF7L2 HIVEP1 HIVEP2 TCF12 CEBPA ESRRG ETV1 NR1D1 ATF2 ZEB2 HIVEP3 BCL11B ZFHX4 NFATC2 HEY1 SKOR2 NFYC MAFB MUC1 LEF1 EP300 CREB3L2 NOBOX FOXC2	2.93e-07	1271	134	26	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	HNF1B CUX2 TCF7L2 HIVEP1 HIVEP2 TCF12 CEBPA ESRRG ETV1 SIM1 NR1D1 ATF2 ZEB2 DUXB HIVEP3 BCL11B ZFHX4 NFATC2 HEY1 SKOR2 NFYC MAFB MUC1 LEF1 EP300 CREB3L2 NOBOX FOXC2	3.47e-07	1459	134	28	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	HNF1B CUX2 TCF7L2 HIVEP1 HIVEP2 TCF12 CEBPA ESRRG ADNP2 ETV1 SIM1 NR1D1 ATF2 ZEB2 DUXB HIVEP3 BCL11B ZFHX4 NFATC2 HEY1 SKOR2 NFYC MAFB LEF1 CREB3L2 NOBOX FOXC2	6.29e-07	1412	134	27	GO:0000981
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	TCF7L2 HIVEP2 TCF12 CEBPA ESRRG ETV1 ATF2 ZEB2 BCL11B NFATC2 NFYC MAFB LEF1 CREB3L2 NOBOX FOXC2	1.13e-06	560	134	16	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	TCF7L2 HIVEP2 TCF12 CEBPA ESRRG ETV1 ATF2 ZEB2 BCL11B NFATC2 NFYC MAFB LEF1 CREB3L2 NOBOX FOXC2	1.30e-06	566	134	16	GO:0001216
GeneOntologyMolecularFunction	histone H2B acetyltransferase activity	ATF2 EP300	4.47e-05	2	134	2	GO:0044013
GeneOntologyMolecularFunction	cAMP response element binding	TCF12 ATF2 CREB3L2	6.22e-05	12	134	3	GO:0035497
GeneOntologyMolecularFunction	transcription factor binding	HDAC9 HNF1B TCF7L2 TCF12 CEBPA MED14 NR1D1 ATF2 PER3 UBN1 NFATC2 HEY1 LEF1 EP300 CRTC2	1.64e-04	753	134	15	GO:0008134
GeneOntologyMolecularFunction	SMAD binding	TCF12 ZMIZ1 ZEB2 SKOR2 EP300	2.85e-04	86	134	5	GO:0046332
GeneOntologyMolecularFunction	cytoskeletal protein binding	MAGI1 TMEM201 XIRP1 ANK3 PEX14 FHOD3 EPS8L1 MAST2 MPRIP SHROOM4 CCDC88C PTPRC RITA1 KIFC3 SSH2 UTRN EP300 NIN	4.02e-04	1099	134	18	GO:0008092
GeneOntologyMolecularFunction	HMG box domain binding	HIVEP1 TCF12 CEBPA	4.74e-04	23	134	3	GO:0071837
GeneOntologyMolecularFunction	chromatin binding	TCF7L2 CEBPA ATF2 TRIM66 ARID1B NFATC2 ATXN7 SKOR2 ANKRD17 LEF1 EP300 CRTC2 FOXC2	1.42e-03	739	134	13	GO:0003682
GeneOntologyMolecularFunction	transcription coregulator activity	HDAC9 TRIM31 MED14 PEX14 ZMIZ1 KMT2E ARID1B SETD5 CAMTA1 MUC1 EP300	1.45e-03	562	134	11	GO:0003712
GeneOntologyMolecularFunction	armadillo repeat domain binding	TCF7L2 LEF1	1.56e-03	9	134	2	GO:0070016
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	HNF1B DRD2 TCF7L2 HIVEP1 HIVEP2 TCF12 CEBPA ESRRG MED14 ETV1 ZMIZ1 NR1D1 ATF2 ZEB2 BCL11B NFATC2 HEY1 ATXN7 NFYC MAFB PRKD1 CAMTA1 MUC1 LEF1 EP300 CRTC2 CREB3L2 NOBOX FOXC2	1.68e-08	1390	134	29	GO:0045944
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	HDAC9 HNF1B CUX2 TCF7L2 HIVEP1 CEBPA PEX14 NR1D1 ATXN1L ZC3H6 ATF2 TENM2 ZEB2 OTUD7B TRIM66 PER3 NFATC2 HEY1 SETD5 SKOR2 RITA1 MAFB MUC1 LEF1 EP300 FOXC2	9.86e-07	1399	134	26	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	HDAC9 HNF1B CUX2 TCF7L2 HIVEP1 CEBPA PEX14 NR1D1 ATXN1L ZC3H6 ATF2 TENM2 ZEB2 OTUD7B TRIM66 PER3 NFATC2 HEY1 SETD5 SKOR2 RITA1 MAFB MUC1 LEF1 EP300 FOXC2	1.19e-06	1413	134	26	GO:1902679
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	HDAC9 HNF1B CUX2 TCF7L2 HIVEP1 CEBPA NR1D1 ATXN1L ATF2 TENM2 ZEB2 OTUD7B PER3 NFATC2 HEY1 SKOR2 RITA1 MAFB LEF1 EP300 FOXC2	4.31e-06	1053	134	21	GO:0000122
GeneOntologyBiologicalProcess	muscle structure development	HDAC9 XIRP1 TCF7L2 TCF12 ETV1 FHOD3 JPH1 HIVEP3 ARID1B NFATC2 HEY1 ANKRD17 PRKD1 LEF1 UTRN SDC1 EP300 FOXC2	1.14e-05	858	134	18	GO:0061061
GeneOntologyBiologicalProcess	central nervous system neuron development	DRD2 ARHGEF28 ZMIZ1 ZEB2 RAPGEF2 NIN	4.59e-05	99	134	6	GO:0021954
GeneOntologyBiologicalProcess	ureteric bud development	HNF1B SIM1 DCHS1 LZTS2 SDC1 FOXC2	7.10e-05	107	134	6	GO:0001657
GeneOntologyBiologicalProcess	mesonephric tubule development	HNF1B SIM1 DCHS1 LZTS2 SDC1 FOXC2	8.28e-05	110	134	6	GO:0072164
GeneOntologyBiologicalProcess	mesonephric epithelium development	HNF1B SIM1 DCHS1 LZTS2 SDC1 FOXC2	8.28e-05	110	134	6	GO:0072163
GeneOntologyBiologicalProcess	central nervous system neuron differentiation	DRD2 ARHGEF28 ZMIZ1 ZEB2 BCL11B SKOR2 RAPGEF2 NIN	8.84e-05	217	134	8	GO:0021953
GeneOntologyBiologicalProcess	mesonephros development	HNF1B SIM1 DCHS1 LZTS2 SDC1 FOXC2	9.61e-05	113	134	6	GO:0001823
GeneOntologyBiologicalProcess	head development	WHRN HNF1B DRD2 TCF7L2 FLVCR2 ZMIZ1 ATXN1L ATF2 ZEB2 SHROOM4 BCL11B SKOR2 MAFB RAPGEF2 LEF1 EP300 NIN	9.74e-05	919	134	17	GO:0060322
GeneOntologyBiologicalProcess	muscle organ development	HDAC9 TCF7L2 TCF12 ETV1 JPH1 HIVEP3 HEY1 LEF1 UTRN EP300 FOXC2	1.33e-04	436	134	11	GO:0007517
GeneOntologyBiologicalProcess	brain development	WHRN HNF1B DRD2 TCF7L2 FLVCR2 ZMIZ1 ATXN1L ATF2 ZEB2 SHROOM4 BCL11B SKOR2 MAFB RAPGEF2 LEF1 NIN	1.46e-04	859	134	16	GO:0007420
GeneOntologyBiologicalProcess	apoptotic process involved in development	HNF1B ATF2 LEF1 FOXC2	2.45e-04	47	134	4	GO:1902742
GeneOntologyCellularComponent	chromatin	HNF1B CUX2 TCF7L2 TCF12 CEBPA ESRRG ADNP2 ETV1 ZMIZ1 SIM1 KMT2E NR1D1 ZC3H6 ATF2 ZEB2 TRIM66 ARID1B BCL11B ZFHX4 NFATC2 HEY1 SETD5 ATXN7 NFYC ANKRD17 MAFB MUC1 LEF1 EP300 CREB3L2 NOBOX FOXC2	1.13e-09	1480	136	32	GO:0000785
GeneOntologyCellularComponent	transcription regulator complex	HDAC9 HNF1B TCF7L2 HIVEP2 TCF12 CEBPA MED14 ATF2 NFATC2 ATXN7 SKOR2 NFYC MAFB LEF1 EP300 NOBOX	1.73e-06	596	136	16	GO:0005667
GeneOntologyCellularComponent	Golgi lumen	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6 SDC1	7.25e-06	109	136	7	GO:0005796
GeneOntologyCellularComponent	apical junction complex	MAGI1 ATP7B ANK3 SHROOM4 CCDC88C UBN1 KIFC3 RAPGEF2	9.26e-06	158	136	8	GO:0043296
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	TCF7L2 TCF12 CEBPA MED14 ATF2 NFATC2 ATXN7 NFYC MAFB LEF1	1.19e-05	272	136	10	GO:0090575
GeneOntologyCellularComponent	anchoring junction	MAGI1 XIRP1 ATP7B ANK3 ARHGEF5 MAST2 TENM2 MPRIP CDC42EP1 SHROOM4 CCDC88C FNDC1 PTPRC UBN1 CLCA2 PRKD1 KIFC3 SSH2 RAPGEF2	1.87e-05	976	136	19	GO:0070161
GeneOntologyCellularComponent	Set3 complex	KMT2E SETD5	4.20e-05	2	136	2	GO:0034967
GeneOntologyCellularComponent	Rpd3L-Expanded complex	KMT2E SETD5	4.20e-05	2	136	2	GO:0070210
GeneOntologyCellularComponent	cell-cell junction	MAGI1 XIRP1 ATP7B ANK3 TENM2 CDC42EP1 SHROOM4 CCDC88C FNDC1 UBN1 PRKD1 KIFC3 RAPGEF2	1.30e-04	591	136	13	GO:0005911
GeneOntologyCellularComponent	CCAAT-binding factor complex	ATF2 NFYC	6.20e-04	6	136	2	GO:0016602
GeneOntologyCellularComponent	bicellular tight junction	MAGI1 ATP7B ANK3 UBN1 RAPGEF2	1.67e-03	131	136	5	GO:0005923
GeneOntologyCellularComponent	centriolar subdistal appendage	CEP170 NIN	1.83e-03	10	136	2	GO:0120103
GeneOntologyCellularComponent	tight junction	MAGI1 ATP7B ANK3 UBN1 RAPGEF2	2.17e-03	139	136	5	GO:0070160
Domain	VWF_type-D	MUC5B MUC4 MUC5AC MUC6	4.19e-06	16	133	4	IPR001846
Domain	VWFD	MUC5B MUC4 MUC5AC MUC6	4.19e-06	16	133	4	PS51233
Domain	VWD	MUC5B MUC4 MUC5AC MUC6	4.19e-06	16	133	4	SM00216
Domain	VWD	MUC5B MUC4 MUC5AC MUC6	4.19e-06	16	133	4	PF00094
Domain	VWC_out	MUC5B VWCE MUC5AC MUC6	8.77e-06	19	133	4	SM00215
Domain	ZF_CCHC_HIVEP	HIVEP1 HIVEP3	5.03e-05	2	133	2	PS51811
Domain	C8	MUC5B MUC5AC MUC6	7.41e-05	12	133	3	PF08742
Domain	TIL	MUC5B MUC5AC MUC6	7.41e-05	12	133	3	PF01826
Domain	Unchr_dom_Cys-rich	MUC5B MUC5AC MUC6	9.58e-05	13	133	3	IPR014853
Domain	C8	MUC5B MUC5AC MUC6	9.58e-05	13	133	3	SM00832
Domain	TIL_dom	MUC5B MUC5AC MUC6	1.21e-04	14	133	3	IPR002919
Domain	VWF_dom	MUC5B VWCE MUC5AC MUC6	2.23e-04	42	133	4	IPR001007
Domain	Tox-GHH_dom	TENM2 TENM1	2.99e-04	4	133	2	IPR028916
Domain	CTNNB1_binding	TCF7L2 LEF1	2.99e-04	4	133	2	PF08347
Domain	SCA7	ATXN7L1 ATXN7	2.99e-04	4	133	2	PF08313
Domain	TCF/LEF	TCF7L2 LEF1	2.99e-04	4	133	2	IPR024940
Domain	DUF1908	MAST2 MAST4	2.99e-04	4	133	2	PF08926
Domain	MA_Ser/Thr_Kinase_dom	MAST2 MAST4	2.99e-04	4	133	2	IPR015022
Domain	Tox-GHH	TENM2 TENM1	2.99e-04	4	133	2	PF15636
Domain	SCA7_dom	ATXN7L1 ATXN7	2.99e-04	4	133	2	IPR013243
Domain	CTNNB1-bd_N	TCF7L2 LEF1	2.99e-04	4	133	2	IPR013558
Domain	Ten_N	TENM2 TENM1	2.99e-04	4	133	2	IPR009471
Domain	Ten_N	TENM2 TENM1	2.99e-04	4	133	2	PF06484
Domain	TENEURIN_N	TENM2 TENM1	2.99e-04	4	133	2	PS51361
Domain	SCA7	ATXN7L1 ATXN7	2.99e-04	4	133	2	PS51505
Domain	MAST_pre-PK_dom	MAST2 MAST4	2.99e-04	4	133	2	IPR023142
Domain	-	MAST2 MAST4	2.99e-04	4	133	2	1.20.1480.20
Domain	CT	MUC5B MUC5AC MUC6	4.92e-04	22	133	3	SM00041
Domain	YD	TENM2 TENM1	4.96e-04	5	133	2	IPR006530
Domain	BRLZ	CEBPA ATF2 MAFB CREB3L2	5.11e-04	52	133	4	SM00338
Domain	PDZ	WHRN MAGI1 MAST2 SHROOM4 MAST4 RAPGEF2	5.20e-04	141	133	6	PF00595
Domain	BZIP_BASIC	CEBPA ATF2 MAFB CREB3L2	5.49e-04	53	133	4	PS00036
Domain	BZIP	CEBPA ATF2 MAFB CREB3L2	5.49e-04	53	133	4	PS50217
Domain	bZIP	CEBPA ATF2 MAFB CREB3L2	5.90e-04	54	133	4	IPR004827
Domain	PDZ	WHRN MAGI1 MAST2 SHROOM4 MAST4 RAPGEF2	6.72e-04	148	133	6	SM00228
Domain	-	WHRN MAGI1 MAST2 SHROOM4 MAST4 RAPGEF2	7.21e-04	150	133	6	2.30.42.10
Domain	Cys_knot_C	MUC5B MUC5AC MUC6	7.24e-04	25	133	3	IPR006207
Domain	CTCK_2	MUC5B MUC5AC MUC6	7.24e-04	25	133	3	PS01225
Domain	WxxW_domain	MUC5B MUC5AC	7.41e-04	6	133	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	7.41e-04	6	133	2	PF13330
Domain	PDZ	WHRN MAGI1 MAST2 SHROOM4 MAST4 RAPGEF2	7.46e-04	151	133	6	PS50106
Domain	PDZ	WHRN MAGI1 MAST2 SHROOM4 MAST4 RAPGEF2	7.72e-04	152	133	6	IPR001478
Domain	VWC	MUC5B VWCE MUC5AC	1.02e-03	28	133	3	PF00093
Domain	VWFC_1	MUC5B VWCE MUC5AC	2.12e-03	36	133	3	PS01208
Domain	TF_DNA-bd	ATF2 MAFB CREB3L2	2.30e-03	37	133	3	IPR008917
Domain	VWFC_2	MUC5B VWCE MUC5AC	2.48e-03	38	133	3	PS50184
Domain	VWC	MUC5B VWCE MUC5AC	2.48e-03	38	133	3	SM00214
Domain	Homeodomain-like	HNF1B CUX2 TCF12 ADNP2 ZEB2 ZFHX4 SSH2 NOBOX	2.63e-03	332	133	8	IPR009057
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	2.85e-10	16	84	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	4.38e-10	17	84	6	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	3.48e-09	23	84	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	7.82e-09	26	84	6	M27483
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC5B MUC1 MUC4 MUC5AC MUC6	1.26e-07	21	84	5	MM15706
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	1.76e-06	62	84	6	M546
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC5B MUC12 NFATC2 MUC1 MUC4 MUC5AC MUC6 EP300	1.79e-06	140	84	8	M27484
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	3.04e-06	68	84	6	M27303
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6 SDC1	2.25e-05	143	84	7	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC5B MUC1 MUC4 MUC5AC MUC6	2.81e-05	60	84	5	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	5.14e-05	111	84	6	M27416
Pathway	REACTOME_HEME_SIGNALING	NR1D1 ATF2 EP300 CRTC2	2.03e-04	49	84	4	M41832
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC5B MUC1 MUC4 MUC5AC MUC6	4.79e-04	109	84	5	MM15164
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	TCF7L2 LEF1 EP300	4.81e-04	26	84	3	MM14793
Pathway	REACTOME_RUNX3_REGULATES_WNT_SIGNALING	TCF7L2 LEF1	5.18e-04	6	84	2	MM15542
Pathway	KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY	TCF7L2 LEF1	5.18e-04	6	84	2	M47736
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	MAGI1 CEBPA TLK1 EP300	6.02e-04	65	84	4	M39682
Pathway	KEGG_THYROID_CANCER	TCF7L2 CCDC6 LEF1	6.67e-04	29	84	3	M523
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6 SDC1	7.19e-04	250	84	7	M27554
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY	TCF7L2 LEF1	7.23e-04	7	84	2	M47465
Pathway	PID_AP1_PATHWAY	TCF7L2 ATF2 NFATC2 EP300	7.98e-04	70	84	4	M167
Pathway	REACTOME_CIRCADIAN_CLOCK	NR1D1 ATF2 EP300 CRTC2	7.98e-04	70	84	4	M938
Pathway	WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR	HDAC9 NFATC2 EP300	8.94e-04	32	84	3	M39521
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION	TCF7L2 LEF1	9.60e-04	8	84	2	MM17229
Pathway	REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS	TCF7L2 LEF1	9.60e-04	8	84	2	M27359
Pathway	KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY	TCF7L2 LEF1	9.60e-04	8	84	2	M47413
Pathway	REACTOME_RUNX3_REGULATES_WNT_SIGNALING	TCF7L2 LEF1	9.60e-04	8	84	2	M27821
Pathway	REACTOME_GASTRULATION	TCF7L2 ZEB2 LEF1 EP300 FOXC2	1.03e-03	129	84	5	M46433
Pathway	WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING	TCF7L2 CEBPA LEF1	1.37e-03	37	84	3	M39817
Pathway	WP_DELTANOTCH_SIGNALING_PATHWAY	HIVEP3 HEY1 LEF1 EP300	1.44e-03	82	84	4	MM15922
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY	TCF7L2 LEF1	1.53e-03	10	84	2	M47486
Pathway	REACTOME_REPRESSION_OF_WNT_TARGET_GENES	TCF7L2 LEF1	1.53e-03	10	84	2	MM15156
Pathway	REACTOME_NGF_STIMULATED_TRANSCRIPTION	TCF12 ATF2 EP300	1.60e-03	39	84	3	M29793
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	HNF1B TCF7L2 TCF12 CEBPA ARHGEF28 ANK3 MED14 ZEB2 DUXB ARID1B PTPRC HEY1 MAFB LEF1 UTRN EP300 NOBOX FOXC2	1.67e-03	1432	84	18	M509
Pubmed	A census of human transcription factors: function, expression and evolution.	CUX2 TCF7L2 HIVEP1 HIVEP2 TCF12 ESRRG ADNP2 ETV1 KIAA1549 NR1D1 ATF2 ZEB2 HIVEP3 BCL11B ZFHX4 NFATC2 HEY1 SKOR2 NFYC MAFB CAMTA1 LEF1 CREB3L2 NOBOX FOXC2	4.61e-14	908	142	25	19274049
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TCF12 ATP7B ATXN7L1 ADNP2 KIAA1549 MAST2 PSMG3-AS1 DCAF5 CDC42EP1 JPH1 CEP170 TRIM66 ARID1B BCL11B SMG7 ZFHX4 COQ8A SETD5 ATXN7 ANKRD17 HELZ LZTS2 RAPGEF2 EP300 NIN	4.27e-12	1116	142	25	31753913
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAGI1 TCF7L2 HIVEP2 ANK3 ATXN7L1 ETV1 PEX14 ZMIZ1 PCNX2 CEP170 HIVEP3 TLK1 SMG7 COQ8A SETD5 ATXN7 OSBPL9 ANKRD17 PRKD1 LZTS2 CAMTA1 RAPGEF2 UTRN SH3RF3 SLC4A5 EP300 CREB3L2	6.56e-11	1489	142	27	28611215
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	7.43e-11	18	142	6	18834073
Pubmed	A human MAP kinase interactome.	HDAC9 MAGI1 HIVEP1 HIVEP2 ANK3 ADNP2 MUC12 CBLB CDC42EP1 TLK1 NFYC ANKRD17 HELZ RAPGEF2 MUC1 EP300	1.79e-10	486	142	16	20936779
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	MAGI1 KIAA1549 CCDC6 MAST2 CDC42EP1 CEP170 CCDC88C ARID1B HELZ LZTS2 RAPGEF2 UTRN SH3RF3 CRTC2 NIN	5.12e-10	446	142	15	24255178
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC1 MUC4 MUC5AC	1.33e-09	5	142	4	11062147
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC1 MUC4 MUC5AC MUC6	1.33e-09	5	142	4	16475027
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 HIVEP1 HIVEP2 ARHGEF28 ARHGEF5 CCDC6 MAST2 MPRIP CDC42EP1 CEP170 CCDC88C MAST4 ANKRD17 HELZ SSH2 RAPGEF2 UTRN SH3RF3 CRTC2	2.60e-09	861	142	19	36931259
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	CUX2 TCF7L2 HIVEP1 HIVEP2 TCF12 CEBPA ESRRG ETV1 SIM1 NR1D1 ATF2 BCL11B NFATC2 HEY1 LEF1 FOXC2	3.79e-08	709	142	16	22988430
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	CUX2 TCF7L2 HIVEP1 TCF12 CEBPA ESRRG ETV1 NR1D1 ZC3H6 ATF2 HIVEP3 PER3 HEY1 NFYC LEF1 CREB3L2 NOBOX	3.81e-08	808	142	17	20412781
Pubmed	A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.	MUC1 MUC5AC MUC6	6.66e-08	3	142	3	19924550
Pubmed	Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.	MUC1 MUC4 MUC6	6.66e-08	3	142	3	23446997
Pubmed	Mucin expression in reactive gastropathy: an immunohistochemical analysis.	MUC1 MUC5AC MUC6	6.66e-08	3	142	3	17227128
Pubmed	Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4.	TCF7L2 LEF1 EP300	6.66e-08	3	142	3	12446687
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 FAM193B HIVEP2 TMEM94 MED14 WRAP53 MAST2 MPRIP PCNX2 HIVEP3 CCDC88C TLK1 CYREN UBN1 SETD5 LRP3 LRRC56 KIFC3 EP300	1.35e-07	1105	142	19	35748872
Pubmed	Interaction network of human early embryonic transcription factors.	TCF7L2 HIVEP1 HIVEP2 ZMIZ1 ATXN1L ZEB2 DUXB ARID1B BCL11B ZFHX4 EP300	2.32e-07	351	142	11	38297188
Pubmed	Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.	MUC5B MUC1 MUC5AC	2.66e-07	4	142	3	25638393
Pubmed	Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.	MUC5B MUC1 MUC5AC	2.66e-07	4	142	3	22269464
Pubmed	Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.	MUC1 MUC5AC MUC6	2.66e-07	4	142	3	24603585
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC5AC MUC6	2.66e-07	4	142	3	23807779
Pubmed	Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.	MUC1 MUC5AC MUC6	2.66e-07	4	142	3	33154304
Pubmed	Gastric mucin expression in first-degree relatives of gastric cancer patients.	MUC1 MUC5AC MUC6	2.66e-07	4	142	3	24901817
Pubmed	Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).	MUC1 MUC5AC MUC6	2.66e-07	4	142	3	36367122
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC5AC MUC6	2.66e-07	4	142	3	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC5AC MUC6	2.66e-07	4	142	3	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC5AC MUC6	2.66e-07	4	142	3	29869461
Pubmed	Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?	MUC1 MUC5AC MUC6	2.66e-07	4	142	3	20929551
Pubmed	Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.	MUC5B MUC1 MUC6	2.66e-07	4	142	3	21596555
Pubmed	MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.	MUC1 MUC5AC MUC6	2.66e-07	4	142	3	27298226
Pubmed	Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.	MUC1 MUC5AC MUC6	2.66e-07	4	142	3	17401217
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC5AC MUC6	2.66e-07	4	142	3	12676567
Pubmed	Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.	MUC1 MUC5AC MUC6	2.66e-07	4	142	3	25298197
Pubmed	Human transcription factor protein interaction networks.	HNF1B TCF7L2 HIVEP1 TCF12 ATXN7L1 CCDC174 ZMIZ1 ATXN1L ZEB2 DCAF5 MPRIP ARID1B SMG7 UBN1 ZFHX4 ATXN7 WDCP NFYC ANKRD17 HELZ EP300	3.78e-07	1429	142	21	35140242
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	VWA5B2 WHRN XIRP1 HIVEP1 KMT2E PCNX2 SPATA31D4 SPATA31D3 ATXN7	5.37e-07	233	142	9	37704626
Pubmed	Differential expression of MUC genes in endometrial and cervical tissues and tumors.	MUC5B MUC1 MUC5AC	6.62e-07	5	142	3	16188033
Pubmed	T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors.	TCF7L2 CEBPA EP300	6.62e-07	5	142	3	12861022
Pubmed	Sip1 downstream Effector ninein controls neocortical axonal growth, ipsilateral branching, and microtubule growth and stability.	ZEB2 BCL11B NIN	6.62e-07	5	142	3	25741725
Pubmed	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	TCF7L2 ARHGEF5 PEX14 ZMIZ1 CCDC88C NOBOX	7.20e-07	76	142	6	23535729
Pubmed	Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression.	TCF7L2 ZEB2 NFATC2 LEF1	9.84e-07	19	142	4	20219685
Pubmed	Molecular characterization of mutant mouse strains generated from the EUCOMM/KOMP-CSD ES cell resource.	TCF7L2 SRRM4 TRIM66 CRTC2	9.84e-07	19	142	4	23912999
Pubmed	Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways.	CUX2 ESRRG ETV1 SIM1 BCL11B HEY1 MAFB	1.13e-06	130	142	7	19386638
Pubmed	Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression.	ZEB2 MUC1 LEF1	1.32e-06	6	142	3	12161443
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC5B MUC5AC MUC6	1.32e-06	6	142	3	19110483
Pubmed	ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules.	TCF7L2 LEF1 EP300	1.32e-06	6	142	3	12408825
Pubmed	Dlx1&2 and Mash1 transcription factors control striatal patterning and differentiation through parallel and overlapping pathways.	CUX2 DRD2 ESRRG ETV1 BCL11B HEY1 MAFB	1.39e-06	134	142	7	19030180
Pubmed	Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning.	HNF1B MAFB LEF1 FOXC2	1.84e-06	22	142	4	29449451
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	CUX2 TCF12 ESRRG ETV1 NR1D1 ATF2 BCL11B NFATC2 HEY1 SKOR2 LEF1 FOXC2	2.62e-06	544	142	12	28473536
Pubmed	Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans.	CUX2 ETV1 ATXN1L BCL11B	3.15e-06	25	142	4	28288114
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MAGI1 XIRP1 ADNP2 MAST2 ZC3H6 DCAF5 OTUD7B SMG7 UBN1 SKOR2 SSH2 LZTS2 FOXC2	5.43e-06	689	142	13	36543142
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TCF7L2 HIVEP1 ADNP2 ZEB2 ARID1B BCL11B ZFHX4 WDCP NFYC EP300	5.98e-06	398	142	10	35016035
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HDAC9 FAM193B ARHGEF28 CEP170 SHROOM4 HIVEP3 CCDC88C TRIM66 TLK1 PER3 SSH2	6.25e-06	493	142	11	15368895
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	TCF7L2 TCF12 ZEB2 CDC42EP1 ZFHX4 ANKRD17 LEF1 CREB3L2 NIN	7.41e-06	321	142	9	32098917
Pubmed	Glycine receptors control the generation of projection neurons in the developing cerebral cortex.	CUX2 ETV1 BCL11B	7.83e-06	10	142	3	24926615
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	TCF12 TLK1 BCL11B NFATC2 NFYC LEF1 EP300	9.09e-06	178	142	7	27637333
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAGI1 ANK3 WDR7 CCDC6 TENM2 ZEB2 MPRIP CEP170 CCDC88C BCL11B DCHS1 ANKRD17 PRKD1 SSH2 RAPGEF2	1.01e-05	963	142	15	28671696
Pubmed	Tcf7L2 is essential for neurogenesis in the developing mouse neocortex.	TCF7L2 BCL11B LEF1	1.07e-05	11	142	3	29751817
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	HNF1B TCF12 ZEB2 CEP170 SMG7 UBN1 LZTS2	1.13e-05	184	142	7	32908313
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	CUX2 TCF7L2 ANK3 ARHGEF5 PEX14 KMT2E OTUD7B UBN1 CAMTA1 CRTC2	1.17e-05	430	142	10	35044719
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	TMEM201 ANK3 KIAA1549 SMG7 TENM1 HELZ LZTS2 UTRN	1.35e-05	263	142	8	34702444
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	1.66e-05	2	142	2	7513696
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	1.66e-05	2	142	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	1.66e-05	2	142	2	14988081
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	1.66e-05	2	142	2	15563276
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	1.66e-05	2	142	2	17621824
Pubmed	MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.	MUC4 MUC5AC	1.66e-05	2	142	2	18475301
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	1.66e-05	2	142	2	24317696
Pubmed	Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.	MUC1 MUC4	1.66e-05	2	142	2	28885228
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	1.66e-05	2	142	2	22391959
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	1.66e-05	2	142	2	35776514
Pubmed	Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis.	MUC1 MUC5AC	1.66e-05	2	142	2	18848467
Pubmed	Involvement of protein kinase D in expression and trafficking of ATP7B (copper ATPase).	ATP7B PRKD1	1.66e-05	2	142	2	21189263
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	1.66e-05	2	142	2	24327612
Pubmed	Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1.	HNF1B LEF1	1.66e-05	2	142	2	33453998
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	1.66e-05	2	142	2	28321513
Pubmed	Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3.	HIVEP2 HIVEP3	1.66e-05	2	142	2	20404140
Pubmed	Evolution of the human MUC1 oncoprotein.	MUC5B MUC1	1.66e-05	2	142	2	17671696
Pubmed	Direct regulation of vHnf1 by retinoic acid signaling and MAF-related factors in the neural tube.	HNF1B MAFB	1.66e-05	2	142	2	17669392
Pubmed	Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.	TCF7L2 LEF1	1.66e-05	2	142	2	21599871
Pubmed	p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha.	CEBPA EP300	1.66e-05	2	142	2	11340085
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	1.66e-05	2	142	2	28607090
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	1.66e-05	2	142	2	31030254
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	1.66e-05	2	142	2	23527003
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	1.66e-05	2	142	2	16540890
Pubmed	Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.	MUC1 MUC4	1.66e-05	2	142	2	27283771
Pubmed	Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells.	MUC1 MUC5AC	1.66e-05	2	142	2	21685325
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	1.66e-05	2	142	2	27845589
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	1.66e-05	2	142	2	27435107
Pubmed	Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.	MUC1 MUC4	1.66e-05	2	142	2	19236510
Pubmed	Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.	MUC1 MUC5AC	1.66e-05	2	142	2	21815153
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	1.66e-05	2	142	2	26871672
Pubmed	Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.	MUC5AC MUC6	1.66e-05	2	142	2	11988092
Pubmed	Glycosylation of mucins present in gastric juice: the effect of helicobacter pylori eradication treatment.	MUC1 MUC5AC	1.66e-05	2	142	2	20953890
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	1.66e-05	2	142	2	14690056
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5B MUC5AC	1.66e-05	2	142	2	11587997
Pubmed	Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients.	MUC1 MUC5AC	1.66e-05	2	142	2	32776556
Pubmed	Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice.	MUC4 MUC5AC	1.66e-05	2	142	2	19158956
Pubmed	MUC expression in adenosquamous carcinoma of the head and neck regions of Japanese patients: immunohistochemical analysis.	MUC1 MUC4	1.66e-05	2	142	2	24698420
Pubmed	Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma.	MUC5B MUC5AC	1.66e-05	2	142	2	34656442
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5B MUC5AC	1.66e-05	2	142	2	34058148
Interaction	TLE3 interactions	HNF1B TCF7L2 HIVEP1 HIVEP2 TCF12 CEBPA ANK3 ZMIZ1 ATXN1L ARID1B BCL11B SMG7 WDCP HELZ EP300 CRTC2	6.64e-09	376	138	16	int:TLE3
Interaction	MAPK8 interactions	HDAC9 FAM193B HIVEP1 CEBPA ETV1 ATF2 CCDC88C NFATC2 WDCP PRKD1 SH3RF3 EP300	2.19e-07	258	138	12	int:MAPK8
Interaction	TBR1 interactions	HNF1B TCF7L2 HIVEP1 ZMIZ1 ATXN1L ARID1B ZFHX4 EP300	1.10e-06	113	138	8	int:TBR1
Interaction	PAX6 interactions	HNF1B TCF7L2 HIVEP1 ESRRG CCDC6 ATXN1L ZEB2 TLK1 ARID1B ZFHX4 NFYC MAFB EP300	1.44e-06	366	138	13	int:PAX6
Interaction	SOX7 interactions	TCF7L2 ADNP2 ZEB2 ARID1B BCL11B ZFHX4 EP300	1.50e-06	82	138	7	int:SOX7
Interaction	FOS interactions	TCF7L2 HIVEP1 TCF12 CEBPA ATF2 MPRIP ARID1B UBN1 NFATC2 ANKRD17 MAFB EP300	1.64e-06	312	138	12	int:FOS
Interaction	GSC interactions	TCF7L2 HIVEP1 ATXN1L ZEB2 ARID1B ZFHX4 EP300	2.24e-06	87	138	7	int:GSC
Interaction	EGR2 interactions	TCF7L2 HIVEP1 HIVEP2 ATXN1L ZEB2 ARID1B BCL11B ZFHX4 EP300	2.77e-06	171	138	9	int:EGR2
Interaction	SOX10 interactions	HNF1B HIVEP1 TCF12 CEBPA ATXN1L ARID1B EP300	3.27e-06	92	138	7	int:SOX10
Interaction	YWHAG interactions	MAGI1 HIVEP1 HIVEP2 ARHGEF28 ARHGEF5 CCDC6 MAST2 ATF2 MPRIP CDC42EP1 CEP170 CCDC88C MAST4 NFATC2 ANKRD17 HELZ MAFB PRKD1 SSH2 LZTS2 RAPGEF2 UTRN SH3RF3 CRTC2	3.90e-06	1248	138	24	int:YWHAG
Interaction	HNF1B interactions	HNF1B TCF7L2 HIVEP1 ATXN1L ZEB2 ARID1B UBN1 ZFHX4 EP300	6.56e-06	190	138	9	int:HNF1B
Interaction	NUP35 interactions	HNF1B TMEM201 TCF7L2 PEX14 ZMIZ1 GMIP HIVEP3 ARID1B SMG7 ANKRD17 HELZ EP300 CRTC2	7.19e-06	424	138	13	int:NUP35
Interaction	PHIP interactions	TCF12 CEP170 TRIM66 BCL11B SMG7 ZFHX4 COQ8A ANKRD17 HELZ	8.78e-06	197	138	9	int:PHIP
Interaction	CRX interactions	HNF1B TCF7L2 ZMIZ1 ATXN1L ZEB2 ARID1B ZFHX4 ATXN7 NFYC EP300	1.02e-05	254	138	10	int:CRX
Interaction	CREB1 interactions	HNF1B HIVEP1 CEBPA CCDC6 ATF2 NFATC2 ANKRD17 EP300 CRTC2 FOXC2	1.02e-05	254	138	10	int:CREB1
Interaction	MAML1 interactions	HDAC9 HNF1B CEBPA ZMIZ1 SMG7 EP300	1.08e-05	73	138	6	int:MAML1
Interaction	PAX8 interactions	HNF1B HIVEP1 ATXN1L ZEB2 ARID1B ZFHX4 EP300	1.14e-05	111	138	7	int:PAX8
Interaction	TBXT interactions	TCF7L2 HIVEP1 ATXN1L ZEB2 ARID1B ZFHX4 EP300	1.52e-05	116	138	7	int:TBXT
Interaction	YWHAH interactions	MAGI1 HIVEP1 HIVEP2 ARHGEF28 ARHGEF5 CCDC6 MAST2 ATXN1L MPRIP CDC42EP1 CEP170 CCDC88C MAST4 ANKRD17 PRKD1 SSH2 RAPGEF2 UTRN SH3RF3 CRTC2 NIN	1.95e-05	1102	138	21	int:YWHAH
Interaction	PAX7 interactions	HNF1B TCF7L2 HIVEP1 ATXN1L ARID1B ZFHX4 EP300	2.34e-05	124	138	7	int:PAX7
Interaction	TEAD1 interactions	TCF7L2 HIVEP1 TCF12 ATXN1L ZEB2 ARID1B ZFHX4 EP300	2.92e-05	176	138	8	int:TEAD1
Interaction	MEF2D interactions	HNF1B CEBPA WRAP53 SMG7 NFATC2 EP300	2.96e-05	87	138	6	int:MEF2D
Interaction	ALG13 interactions	TCF7L2 ATXN1L TRIM66 ARID1B SMG7 HELZ LZTS2 EP300	3.85e-05	183	138	8	int:ALG13
Interaction	SP7 interactions	HNF1B TCF7L2 HIVEP1 ZMIZ1 CBLB ATXN1L ZEB2 ARID1B ZFHX4 EP300	4.75e-05	304	138	10	int:SP7
Interaction	SMAD3 interactions	HIVEP1 TCF12 CEBPA ANK3 ZMIZ1 ATF2 ZEB2 ARID1B HEY1 NFYC LEF1 EP300	5.99e-05	447	138	12	int:SMAD3
Interaction	GATA2 interactions	TCF7L2 HIVEP1 CEBPA ATXN1L ZEB2 ARID1B ZFHX4 EP300	6.96e-05	199	138	8	int:GATA2
Interaction	HLF interactions	ESRRG TLK1 PER3	8.54e-05	13	138	3	int:HLF
Interaction	BICRA interactions	HNF1B CEBPA TRIM66 ARID1B NFYC	9.62e-05	67	138	5	int:BICRA
Interaction	GCM1 interactions	TCF7L2 HIVEP1 ATXN1L ARID1B EP300	1.03e-04	68	138	5	int:GCM1
Interaction	EN1 interactions	HIVEP1 ATXN1L ZEB2 DCAF5 ZFHX4 EP300	1.10e-04	110	138	6	int:EN1
Interaction	FOSL1 interactions	CEBPA ATF2 MAFB KIFC3 EP300	1.19e-04	70	138	5	int:FOSL1
Interaction	YWHAE interactions	HDAC9 HIVEP1 HIVEP2 ARHGEF28 ARHGEF5 CCDC6 MAST2 MPRIP CDC42EP1 CEP170 CCDC88C TLK1 MAST4 NFATC2 ANKRD17 PRKD1 SSH2 RAPGEF2 SH3RF3 CRTC2 NIN	1.28e-04	1256	138	21	int:YWHAE
Interaction	ETS1 interactions	HIVEP1 CEBPA ZMIZ1 ATF2 ARID1B EP300	1.86e-04	121	138	6	int:ETS1
Interaction	EPAS1 interactions	TCF7L2 TCF12 MED14 OTUD7B ARID1B PRKD1 EP300	1.92e-04	173	138	7	int:EPAS1
Interaction	YWHAB interactions	MAGI1 HIVEP1 ARHGEF28 ARHGEF5 CCDC6 MAST2 ATF2 MPRIP CDC42EP1 CEP170 CCDC88C MAST4 NFATC2 ANKRD17 SSH2 RAPGEF2 SH3RF3 CRTC2	1.96e-04	1014	138	18	int:YWHAB
Interaction	HDAC1 interactions	HDAC9 HNF1B TCF7L2 HIVEP1 CEBPA PEX14 ZMIZ1 CCDC6 KMT2E ZEB2 BCL11B ZFHX4 NFATC2 NFYC ANKRD17 LEF1 UTRN EP300 S100PBP	2.01e-04	1108	138	19	int:HDAC1
Interaction	TLX1 interactions	TCF7L2 HIVEP1 ATXN1L ZEB2 ARID1B ZFHX4 EP300	2.06e-04	175	138	7	int:TLX1
Interaction	JUND interactions	CEBPA ATF2 UBN1 NFATC2 EP300	2.10e-04	79	138	5	int:JUND
Interaction	ZBTB7B interactions	TCF7L2 TCF12 ZEB2 CDC42EP1 ZFHX4 ANKRD17 LEF1 EP300 CREB3L2 NIN	2.18e-04	366	138	10	int:ZBTB7B
Interaction	HNF1A interactions	HNF1B TCF7L2 CEBPA ATXN1L EP300	2.23e-04	80	138	5	int:HNF1A
Interaction	YWHAZ interactions	HDAC9 HIVEP1 HIVEP2 ARHGEF28 WDR7 ARHGEF5 CCDC6 MAST2 MPRIP CDC42EP1 CEP170 CCDC88C MAST4 NFATC2 ANKRD17 PRKD1 SSH2 RAPGEF2 EP300 CRTC2 NIN	2.50e-04	1319	138	21	int:YWHAZ
Interaction	SP4 interactions	HIVEP1 CEBPA ATXN7L1 NFYC	2.75e-04	46	138	4	int:SP4
Interaction	TUBB4A interactions	CCNJL CEBPA TRIM31 PEX14 CCDC6 HEY1 EP300 NIN	2.83e-04	244	138	8	int:TUBB4A
Interaction	PAX2 interactions	HNF1B HIVEP1 ATXN1L ARID1B ZFHX4	2.96e-04	85	138	5	int:PAX2
Interaction	MAPK9 interactions	HDAC9 ATXN7L1 ATF2 NFATC2 LRRC56 PRKD1 SH3RF3	2.99e-04	186	138	7	int:MAPK9
Interaction	GATA3 interactions	TCF7L2 HIVEP1 FHOD3 DCAF5 ARID1B ZFHX4 EP300	3.09e-04	187	138	7	int:GATA3
Interaction	NFIA interactions	HNF1B TCF7L2 HIVEP1 ATXN1L ARID1B EP300 FOXC2	3.19e-04	188	138	7	int:NFIA
Interaction	SMG7 interactions	HIVEP1 CCDC6 TRIM66 ARID1B SMG7 ANKRD17 HELZ LZTS2 NIN	3.58e-04	319	138	9	int:SMG7
Interaction	N4BP2 interactions	PEX14 CCDC6 ANKRD17 LZTS2 EP300	3.66e-04	89	138	5	int:N4BP2
Interaction	ARNT interactions	TCF7L2 TCF12 CEBPA SIM1 MPRIP SMG7 HEY1 EP300	3.80e-04	255	138	8	int:ARNT
Interaction	MYOD1 interactions	TCF7L2 HIVEP1 TCF12 ZEB2 ARID1B HEY1 EP300	3.85e-04	194	138	7	int:MYOD1
GeneFamily	CD molecules\|Mucins	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	5.72e-10	21	88	6	648
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ADNP2 ZEB2 ZFHX4	4.86e-05	15	88	3	529
GeneFamily	Basic leucine zipper proteins	CEBPA ATF2 MAFB CREB3L2	9.39e-05	49	88	4	506
GeneFamily	PDZ domain containing	WHRN MAGI1 MAST2 SHROOM4 MAST4 RAPGEF2	9.83e-05	152	88	6	1220
GeneFamily	Zinc fingers CCCH-type	ZC3H12B ZC3H6 HELZ	6.52e-04	35	88	3	73
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	UTRN EP300	3.41e-03	18	88	2	91
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TCF7L2 HIVEP1 HIVEP2 TCF12 WDR7 ZMIZ1 CBLB ATF2 CEP170 TLK1 NFYC ANKRD17 HELZ RAPGEF2 CREB3L2	2.65e-08	466	138	15	M13522
Coexpression	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP	HDAC9 HIVEP1 HIVEP2 CCDC174 ADNP2 ZC3H12B WRAP53 KMT2E NR1D1 ZEB2 PER3 DCHS1 MUC6 CRTC2 FOXC2	4.59e-08	486	138	15	M34018
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TCF7L2 HIVEP1 HIVEP2 TCF12 WDR7 PEX14 ZMIZ1 CCDC6 MAST2 CBLB ATF2 ZEB2 CEP170 TLK1 NFYC ANKRD17 HELZ RAPGEF2 CREB3L2	1.26e-07	856	138	19	M4500
Coexpression	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP	ARHGEF5 ESRRG ETV1 FLVCR2 MAST2 CDC42EP1 BCL11B PER3 LEF1	1.02e-06	196	138	9	M4999
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	HIVEP2 GMIP KMT2E ZNF831 CBLB ZC3H6 ATF2 ZEB2 DCAF5 PCNX2 HIVEP3 CCDC88C TLK1 BCL11B PTPRC NFATC2 SETD5 ATXN7 HELZ SSH2 UTRN EP300 NIN	3.29e-06	1492	138	23	M40023
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	HIVEP2 ZMIZ1 CBLB ATF2 CEP170 TLK1 MAST4 HELZ RAPGEF2 CREB3L2	4.52e-06	300	138	10	M8702
Coexpression	CUI_TCF21_TARGETS_2_DN	HIVEP1 HIVEP2 ATXN7L1 CBLB TENM2 ZEB2 DCAF5 MPRIP OTUD7B PTPRC MAST4 ATXN7 MAFB RAPGEF2 EP300 FOXC2	1.15e-05	854	138	16	M1533
Coexpression	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	PDXDC1 ARHGEF28 ANK3 EPS8L1 FLVCR2 ATXN1L OTUD7B PRRT3 RAPGEF2 MUC1 UTRN SDC1 CREB3L2	1.33e-05	583	138	13	M17454
Coexpression	CUI_TCF21_TARGETS_2_DN	HIVEP1 HIVEP2 ATXN7L1 CBLB TENM2 ZEB2 DCAF5 MPRIP OTUD7B PTPRC MAST4 ATXN7 MAFB RAPGEF2 EP300 FOXC2	1.86e-05	888	138	16	MM1018
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	HNF1B ANK3 SRRM4 ESRRG KIAA1549 FHOD3 ZMIZ1 KMT2E VWCE TENM2 JPH1 HIVEP3 BCL11B MAST4 ZFHX4 TENM1 SSH2 CAMTA1	2.12e-05	1106	138	18	M39071
Coexpression	GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP	HDAC9 TCF12 MED14 KMT2E HIVEP3 NFATC2 MAFB	2.39e-05	161	138	7	M7728
Coexpression	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	HDAC9 HIVEP1 HIVEP2 CCDC174 ZC3H12B WRAP53 NR1D1 ZEB2 PER3 DCHS1 CRTC2 FOXC2	3.28e-05	545	138	12	M34016
Coexpression	NABA_ECM_AFFILIATED	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6 SDC1	3.39e-05	170	138	7	M5880
Coexpression	LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED	TCF12 KMT2E SSH2 UTRN	4.72e-05	38	138	4	M39244
Coexpression	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	BCL11B PTPRC LEF1 UTRN	4.72e-05	38	138	4	M1751
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	TCF12 CEBPA ETV1 CCDC6 BCL11B MAFB MUC1 EP300 NIN	5.59e-05	323	138	9	M9150
Coexpression	ZHENG_BOUND_BY_FOXP3	HIVEP2 TCF12 CBLB TLK1 BCL11B PTPRC ATXN7 SSH2 RAPGEF2 LEF1 UTRN	6.87e-05	498	138	11	M1741
Coexpression	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	BCL11B PTPRC LEF1 UTRN	7.05e-05	42	138	4	MM733
Coexpression	ZHENG_BOUND_BY_FOXP3	HIVEP2 TCF12 CBLB TLK1 BCL11B PTPRC ATXN7 SSH2 RAPGEF2 LEF1 UTRN	8.05e-05	507	138	11	MM1030
Coexpression	GSE15215_CD2_POS_VS_NEG_PDC_UP	CCNJL WRAP53 MAST2 CDC42EP1 HIVEP3 UBN1 MROH7	8.07e-05	195	138	7	M3519
Coexpression	GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	TCF12 ATXN7L1 GCGR EPS8L1 ZMIZ1 ATXN1L MAST4	9.16e-05	199	138	7	M9498
Coexpression	GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN	HIVEP2 EPS8L1 BCL11B ATXN7 LEF1 UTRN CREB3L2	9.45e-05	200	138	7	M5724
Coexpression	KRAS.KIDNEY_UP.V1_UP	ANK3 ESRRG ETV1 GCGR HEY1 MAFB	1.01e-04	140	138	6	M2892
Coexpression	RUIZ_TNC_TARGETS_UP	TCF12 CBLB CLCA2 HEY1 MAFB LEF1	1.82e-04	156	138	6	M988
Coexpression	GSE11386_NAIVE_VS_MEMORY_BCELL_DN	TCF12 CBLB INSYN2B LEF1 UTRN S100PBP	1.95e-04	158	138	6	M372
Coexpression	NABA_ECM_AFFILIATED	MUC5B MUC1 MUC4 MUC5AC MUC6 SDC1	1.95e-04	158	138	6	MM17063
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	HDAC9 CUX2 TCF7L2 MED14 ETV1 KIAA1549 ZMIZ1 SIM1 KMT2E ZC3H6 TENM2 ZEB2 CEP170 BCL11B ZFHX4 WDCP TENM1 INSYN2B LEF1 UTRN SDC1	1.76e-08	769	135	21	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_200	SIM1 BCL11B ZFHX4 INSYN2B LEF1	1.97e-05	52	135	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000	HDAC9 TCF7L2 ETV1 KIAA1549 SIM1 CEP170 BCL11B ZFHX4 TENM1 INSYN2B LEF1	3.00e-05	377	135	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500	MED14 ZMIZ1 SIM1 TENM2 ZEB2 BCL11B ZFHX4 WDCP TENM1 INSYN2B LEF1	4.08e-05	390	135	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	WHRN MAGI1 CUX2 TCF7L2 ARHGEF5 SRRM4 MED14 PRR30 FHOD3 ZMIZ1 SIM1 JPH1 HIVEP3 CCDC88C FNDC1 BCL11B MAFB SH3RF3	5.40e-05	986	135	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000	CUX2 MED14 ETV1 ZMIZ1 ZC3H6 ZEB2 WDCP UTRN	5.86e-05	209	135	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	HDAC9 CUX2 ETV1 ZMIZ1 ZC3H6 ATF2 TENM2 CEP170 BCL11B ZFHX4 CLCA2 SETD5 WDCP TENM1 LEF1 S100PBP	6.50e-05	818	135	16	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200	SIM1 TENM2 BCL11B ZFHX4 WDCP INSYN2B LEF1	6.63e-05	157	135	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500	HNF1B SRRM4 ETV1 SSC5D BCL11B CATSPER1 ZFHX4 MAFB LEF1 MUC4 SH3RF3 MUC6	7.36e-05	492	135	12	Facebase_RNAseq_e10.5_Maxillary Arch_500
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	ANK3 ESRRG MED14 KIAA1549 ZMIZ1 SIM1 CBLB WDCP MUC1 UTRN	1.59e-04	379	135	10	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	HNF1B TCF7L2 CCDC174 ESRRG ETV1 SIM1 JPH1 BCL11B UBN1 ZFHX4 WDCP LEF1 MUC4 UTRN MUC6 CREB3L2 NIN	1.73e-04	985	135	17	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000	CCNJL MAGI1 HNF1B CUX2 ARHGEF28 KIAA1549 FHOD3 EPS8L1 SIM1 CCDC88C BCL11B SMG7 TENM1 SSH2 MUC1	2.10e-04	813	135	15	gudmap_developingKidney_e11.5_ureteric bud_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500	HNF1B ANK3 ESRRG MED14 FHOD3 ZMIZ1 SIM1 TENM2 WDCP MUC1	2.55e-04	402	135	10	gudmap_developingKidney_e15.5_anlage of loop of Henle_500
CoexpressionAtlas	kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_100	HNF1B CUX2 SIM1 HEY1 FOXC2	2.61e-04	89	135	5	gudmap_kidney_P4_CapMesRenVes_Crym_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000	HDAC9 TENM2 CEP170 BCL11B ZFHX4 TENM1 LEF1	2.62e-04	196	135	7	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#1_top-relative-expression-ranked_200	HNF1B ESRRG FHOD3	2.65e-04	20	135	3	gudmap_developingKidney_e14.5 whole kidney - wildtype_200_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	HDAC9 SRRM4 ETV1 SIM1 ZC3H6 TENM2 ZEB2 CEP170 TLK1 BCL11B ZFHX4 CLCA2 TENM1 INSYN2B LEF1	2.84e-04	836	135	15	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	HDAC9 ANK3 ESRRG ETV1 ZC3H6 TENM2 ZFHX4 CLCA2 SETD5 WDCP	2.87e-04	408	135	10	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 TCF12 ANK3 ATXN7L1 ESRRG FHOD3 ARID1B MAST4 ANKRD17 SSH2 RAPGEF2	2.91e-11	192	141	11	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MAGI1 XIRP1 ANK3 ESRRG FHOD3 MAST2 TENM2 JPH1 MAST4	9.77e-09	189	141	9	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	MAGI1 XIRP1 ANK3 ESRRG FHOD3 MAST2 TENM2 JPH1 MAST4	1.02e-08	190	141	9	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-T_cells-CD4+_T_cells\|COVID-19 / group, cell type (main and fine annotations)	ANK3 ZNF831 CBLB PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	1.07e-08	191	141	9	0646cca78e24aeb6baa9934d3c439b797c567997
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	ANK3 ZNF831 CBLB PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	1.07e-08	191	141	9	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	COVID-19-lung-CD4+_Treg\|lung / Disease (COVID-19 only), tissue and cell type	ANK3 ZNF831 CBLB PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	1.07e-08	191	141	9	73ea3078c1f55cd47e4d99e77b3ce4ff17549d49
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF831 CBLB PCNX2 CCDC88C BCL11B PTPRC NFATC2 PZP LEF1	1.17e-08	193	141	9	b9769b45125d2244afe53f9f71c92c04ddccf980
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HIVEP2 ZNF831 CBLB PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	1.23e-08	194	141	9	3d6f2d190dd50804afea299957cc44c2bb756134
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 HNF1B ARHGEF28 ANK3 ESRRG FHOD3 SIM1 MAST4 KIFC3	1.23e-08	194	141	9	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 HNF1B ARHGEF28 ANK3 ESRRG FHOD3 SIM1 MAST4 KIFC3	1.28e-08	195	141	9	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 HNF1B ARHGEF28 ANK3 ESRRG FHOD3 SIM1 MAST4 ZFHX4	1.34e-08	196	141	9	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 HNF1B ARHGEF28 ANK3 ESRRG FHOD3 SIM1 MAST4 KIFC3	1.34e-08	196	141	9	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 TCF12 ARHGEF28 ANK3 ESRRG ARID1B SSH2 RAPGEF2 UTRN	1.53e-08	199	141	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRIM31 ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 TENM1 PZP	1.60e-08	200	141	9	510d84bf7a4621b079e5a7330d25e04508c84a49
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	TRIM31 FHOD3 MUC5B CLCA2 MUC1 MUC4 MUC6 SDC1	8.32e-08	173	141	8	c2d973356c40e0284fd3bd7733a164b141c66008
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|367C / Donor, Lineage, Cell class and subclass (all cells)	TRIM31 FHOD3 MUC5B CLCA2 MUC1 MUC4 MUC6 SDC1	8.32e-08	173	141	8	d8e965ff7e9b758876ec1521c1ccedd739e8d673
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCNJL HNF1B ZC3H12B CDC42EP1 FNDC1 MUC1 SLC4A5 SDC1	1.04e-07	178	141	8	f3b5eeca6081d65d48824b5d13e3b8eb5fdeb2dd
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	HDAC9 XIRP1 ANK3 ESRRG FHOD3 TENM2 JPH1 MAST4	1.23e-07	182	141	8	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	HDAC9 MAGI1 ANK3 ESRRG ETV1 FHOD3 TENM2 MAST4	1.39e-07	185	141	8	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	ZNF831 CBLB ZEB2 CCDC88C BCL11B PTPRC NFATC2 PZP	1.39e-07	185	141	8	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF831 CBLB PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	1.64e-07	189	141	8	df30478b288084a1bd48f660409dcc784040897c
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	ARHGEF28 ANK3 FHOD3 MUC5B CLCA2 MUC4 MUC5AC SDC1	1.64e-07	189	141	8	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 ANK3 ESRRG SIM1 ARID1B ANKRD17 PRKD1 UTRN	1.64e-07	189	141	8	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ZNF831 CCDC88C BCL11B PTPRC TENM1 SSH2 PZP LEF1	1.71e-07	190	141	8	2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9
ToppCell	Adult-Immune-T_lymphocyte-D175\|Adult / Lineage, Cell type, age group and donor	HIVEP2 ZNF831 PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	1.78e-07	191	141	8	0b84fd1dc68146d9f72422b102744d2847f5ecb2
ToppCell	COVID-19-lung-CD4+_Treg\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK3 ZNF831 PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	1.78e-07	191	141	8	5a4ad5ae5c2dbfb225158cb598ef649c26a48350
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF831 PCNX2 CCDC88C BCL11B PTPRC NFATC2 PZP LEF1	1.78e-07	191	141	8	c7be771543089fc94e5c62fd22f745189642aec3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 ZNF831 CBLB CCDC88C BCL11B NFATC2 TENM1 PZP	1.78e-07	191	141	8	4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 ARHGEF28 FLVCR2 KMT2E ARID1B HELZ PRKD1 UTRN	1.85e-07	192	141	8	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 HNF1B ARHGEF28 ANK3 ESRRG FHOD3 MAST4 KIFC3	1.93e-07	193	141	8	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 HNF1B ARHGEF28 ANK3 ESRRG FHOD3 MAST4 KIFC3	1.93e-07	193	141	8	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	COVID-19-lung-CD8+_T_cells\|lung / Disease (COVID-19 only), tissue and cell type	ZNF831 CBLB PCNX2 CCDC88C BCL11B PTPRC NFATC2 PZP	1.93e-07	193	141	8	780e23e2705fc5c1b70e37568b79731ced5038bd
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 ARHGEF28 FLVCR2 KMT2E ARID1B SETD5 HELZ UTRN	1.93e-07	193	141	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 TENM1 PZP	1.93e-07	193	141	8	1cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 HNF1B ARHGEF28 ANK3 ESRRG FHOD3 SIM1 KIFC3	2.01e-07	194	141	8	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	ANK3 ZNF831 PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	2.01e-07	194	141	8	2a144a1c2d537c8a59aa419206ddd96c23f0aeab
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 HNF1B ARHGEF28 ANK3 ESRRG FHOD3 SIM1 KIFC3	2.17e-07	196	141	8	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARHGEF28 ANK3 CBLB ARID1B BCL11B TENM1 PZP UTRN	2.26e-07	197	141	8	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 INSYN2B PZP	2.53e-07	200	141	8	02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CEBPA ATP7B ANK3 MUC5B CCDC88C MUC1 SDC1	4.51e-07	147	141	7	aba44c7057096483c4293a7ebcf8ccc8baed0231
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIM31 ZNF831 SSC5D BCL11B NFATC2 TENM1 PZP	5.66e-07	152	141	7	669d8f12fdb110ed72f4e5348b7b5350144a061c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HIVEP1 HIVEP2 ANK3 OTUD7B BCL11B ANKRD17 LEF1	1.07e-06	167	141	7	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial-AT2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	HNF1B CEBPA ATP7B ANK3 PER3 MUC1 SDC1	1.51e-06	176	141	7	ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDXDC1 ATP7B ANK3 MUC5B EPS8L1 MUC4 MUC5AC	1.69e-06	179	141	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Adult-Immune-T_lymphocyte-D122\|Adult / Lineage, Cell type, age group and donor	ZNF831 PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	1.76e-06	180	141	7	06c371d0f0c5a7b234dd143e98800e19af95a8b5
ToppCell	COVID-19-kidney-NK\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZNF831 ZEB2 CCDC88C BCL11B PTPRC NFATC2 PZP	1.82e-06	181	141	7	8906ee8a7a1616dfe8c3b5c73988416641213629
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	TCF12 ANK3 CBLB ARID1B BCL11B PTPRC LEF1	1.82e-06	181	141	7	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HIVEP2 ANK3 MPRIP PCNX2 BCL11B MAST4 LEF1	1.89e-06	182	141	7	1aea96ee211f7b9caef7fd385233f51be6021a73
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MAGI1 ARHGEF28 ETV1 JPH1 SHROOM4 DCHS1 INSYN2B	1.89e-06	182	141	7	997d37ca2af661c92a56add888762724dfccc890
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HIVEP2 ANK3 MPRIP PCNX2 BCL11B MAST4 LEF1	1.89e-06	182	141	7	b427e43ee523a3ea9eca3207f3d82042f10f022a
ToppCell	CF-Lymphoid-T_cell_&_NK_cell\|CF / Disease state, Lineage and Cell class	ZNF831 CBLB PCNX2 CCDC88C BCL11B NFATC2 LEF1	1.89e-06	182	141	7	a8dfc59a3974e3433f434676b7c2749d0fcfc8b2
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HIVEP2 ANK3 MPRIP PCNX2 BCL11B MAST4 LEF1	1.89e-06	182	141	7	c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	VWA5B2 SRRM4 ESRRG FHOD3 TENM2 TRIM66 CAMTA1	1.89e-06	182	141	7	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 SRRM4 MUC5B JPH1 MUC1 MUC5AC MUC6	1.89e-06	182	141	7	dc29e8735c3562ce32322351d28f7d9709208ebf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HIVEP2 ANK3 MPRIP PCNX2 BCL11B MAST4 LEF1	1.89e-06	182	141	7	4cb182ef39be2044a6ad7266f332d4177591e550
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	HDAC9 MAGI1 XIRP1 ANK3 ESRRG TENM2 MAST4	2.03e-06	184	141	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDXDC1 MUC5B EPS8L1 MUC1 MUC4 MUC5AC MUC6	2.03e-06	184	141	7	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HNF1B ARHGEF28 ANK3 ETV1 PRKD1 MUC1 SLC4A5	2.11e-06	185	141	7	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	CCNJL MAGI1 ANK3 MAST4 MUC1 MUC4 SLC4A5	2.11e-06	185	141	7	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Control-T_cells-CD8+_T_cells\|Control / group, cell type (main and fine annotations)	ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 PZP	2.11e-06	185	141	7	02ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF831 CBLB CCDC88C BCL11B NFATC2 ATXN7 TENM1	2.18e-06	186	141	7	bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	MAGI1 ARHGEF28 CCDC88C MAST4 HEY1 RAPGEF2 UTRN	2.26e-06	187	141	7	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 LEF1	2.26e-06	187	141	7	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	COVID-19-kidney\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HNF1B ARHGEF28 ANK3 ESRRG FHOD3 SIM1 PRKD1	2.26e-06	187	141	7	d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CDC42EP1 FNDC1 ZFHX4 HEY1 P2RX6 PRKD1 FOXC2	2.34e-06	188	141	7	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	COVID-19-T_cells-CD8+_T_cells\|COVID-19 / group, cell type (main and fine annotations)	ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 PZP	2.43e-06	189	141	7	2c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 PZP	2.43e-06	189	141	7	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 CCDC6 TLK1 BCL11B LEF1 UTRN NIN	2.51e-06	190	141	7	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDXDC1 MUC5B EPS8L1 MUC1 MUC4 MUC5AC MUC6	2.51e-06	190	141	7	23f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	ZNF831 CBLB PCNX2 CCDC88C BCL11B PTPRC LEF1	2.51e-06	190	141	7	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	COVID-19-kidney-NK\|kidney / Disease (COVID-19 only), tissue and cell type	ZNF831 ZEB2 CCDC88C BCL11B PTPRC NFATC2 PZP	2.51e-06	190	141	7	e3ca3c9fb9e27670a5dd128dd6564ff98a57159e
ToppCell	IPF-Epithelial-Goblet\|IPF / Disease state, Lineage and Cell class	MUC5B EPS8L1 MAST4 CLCA2 MUC4 MUC5AC SDC1	2.51e-06	190	141	7	e41dd5a997ad9952810ffecb57737c03ea1d88b3
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDXDC1 MUC5B EPS8L1 MUC1 MUC4 MUC5AC MUC6	2.51e-06	190	141	7	3c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 HNF1B ANK3 ETV1 SHROOM4 MAST4 PRKD1	2.60e-06	191	141	7	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	COVID-19-lung-CD8+_T_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 PZP	2.60e-06	191	141	7	543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF831 CCDC88C BCL11B PTPRC NFATC2 TENM1 PZP	2.60e-06	191	141	7	6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ZNF831 CCDC88C BCL11B PTPRC TENM1 PZP LEF1	2.69e-06	192	141	7	92f141d5ac462f652f405efa73ac6ef751f40ea3
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ZNF831 CCDC88C BCL11B PTPRC TENM1 PZP LEF1	2.69e-06	192	141	7	69a2b04f03a1b82d067018379f7b8a116e954040
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	MAGI1 ANK3 ESRRG FHOD3 MAST2 TENM2 MAST4	2.69e-06	192	141	7	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	IPF-Lymphoid-T\|World / Disease state, Lineage and Cell class	ANK3 ZNF831 CBLB CCDC88C BCL11B PTPRC LEF1	2.69e-06	192	141	7	b25ba1f3bc842c22602b2aeed3b1b5082863e4fa
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZNF831 PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	2.79e-06	193	141	7	326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a
ToppCell	Adult-Immune-T_lymphocyte\|Adult / Lineage, Cell type, age group and donor	ZNF831 PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	2.79e-06	193	141	7	26df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCell	IPF-Lymphoid-T_Cytotoxic\|World / Disease state, Lineage and Cell class	ZNF831 CBLB CCDC88C BCL11B PTPRC NFATC2 PZP	2.79e-06	193	141	7	35c902a983d7f1156a74fe68ee366609029833b3
ToppCell	COVID-19-kidney-T-cells-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZNF831 PCNX2 CCDC88C BCL11B PTPRC NFATC2 LEF1	2.79e-06	193	141	7	5b84fa640cf30dea55fde53b810f850ff946d253
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF831 CBLB ZEB2 BCL11B NFATC2 TENM1 PZP	2.79e-06	193	141	7	523e2541f9f8d22b3c5263839a57cc1ab23d4963
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 ARHGEF28 ANK3 ESRRG FHOD3 MAST4 KIFC3	2.89e-06	194	141	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CCNJL MAGI1 HNF1B ANK3 ETV1 MAST4 PRKD1	2.89e-06	194	141	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	Immune-T_lymphocyte\|World / Lineage, Cell type, age group and donor	ZNF831 CCDC88C BCL11B PTPRC NFATC2 PZP LEF1	2.89e-06	194	141	7	f47fa18c87b35a3960557f8169ff7830dd6ecb80
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HIVEP2 ANK3 KMT2E MPRIP BCL11B MAST4 LEF1	2.99e-06	195	141	7	4bdedd924564a260841a9153604026b57487c83d
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	ANK3 CCDC6 ZNF831 PCNX2 BCL11B MAST4 LEF1	2.99e-06	195	141	7	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CBLB ZEB2 CCDC88C BCL11B NFATC2 TENM1 PZP	2.99e-06	195	141	7	14a6466524c22920daa622fbc710daf1defb46c3
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 TCF12 ANK3 HIVEP3 ARID1B PRKD1 RAPGEF2	3.09e-06	196	141	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	(01)_IL1RL1+-(1)_GFP\|(01)_IL1RL1+ / shred by cell type by condition	HDAC9 FAM193B MUC5B TENM2 CLCA2 MUC1 SDC1	3.09e-06	196	141	7	b598b1112242534e139318012b257ed3cb09da83
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRIM31 MUC5B EPS8L1 MUC1 MUC4 MUC5AC SDC1	3.09e-06	196	141	7	a52879a4c822c5e4be569f01f845a795e00c5f4b
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC5B CLCA2 HEY1 MUC1 MUC4 MUC5AC SDC1	3.09e-06	196	141	7	a4d05d85fbafa869df19bba3881020ea433d81fb
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CBLB ZEB2 CCDC88C BCL11B NFATC2 TENM1 PZP	3.09e-06	196	141	7	51c750a0fb2b87e17e62b984c91fb16f676d7e76
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MUC5B CLCA2 HEY1 MUC1 MUC4 MUC5AC SDC1	3.09e-06	196	141	7	91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC5B CLCA2 HEY1 MUC1 MUC4 MUC5AC SDC1	3.09e-06	196	141	7	e819088a74d29e958371aa851ac9c74ec55367b7
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MUC5B CLCA2 HEY1 MUC1 MUC4 MUC5AC SDC1	3.09e-06	196	141	7	e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRIM31 MUC5B EPS8L1 MUC1 MUC4 MUC5AC SDC1	3.09e-06	196	141	7	7a4d502550e9e37dc42f2ff1be3c896afe365d7f
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	TCF7L2 HIVEP2 TCF12 PEX14 ZMIZ1 CBLB MAST4 ZFHX4 OSBPL9 ANKRD17 RAPGEF2	7.26e-09	171	137	11	7535_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	WHRN TCF7L2 PEX14 MUC5B NR1D1 TLK1 BCL11B MAST4 ZFHX4	2.64e-06	193	137	9	3378_DN
Drug	carmustine; Down 200; 100uM; MCF7; HT_HG-U133A	MAGI1 PCNX2 CCDC88C BCL11B MAST4 HEY1 RAPGEF2 MUC5AC UTRN	3.39e-06	199	137	9	6888_DN
Drug	Methylene Chloride	CUX2 HIVEP2 NR1D1 CBLB PER3 ZFHX4 MAFB CREB3L2	6.64e-06	163	137	8	ctd:D008752
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	TCF7L2 HIVEP1 HIVEP2 WDR7 CBLB TLK1 MAST4 RAPGEF2	1.07e-05	174	137	8	7530_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	HIVEP1 EPS8L1 ZMIZ1 CDC42EP1 TLK1 MAST4 SMG7 EP300	1.21e-05	177	137	8	6434_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	TCF7L2 ADNP2 ZMIZ1 CBLB TLK1 SETD5 RAPGEF2 EP300	1.37e-05	180	137	8	4541_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HG-U133A	HNF1B MED14 PEX14 EPS8L1 WRAP53 LRP3 RITA1 MUC1	2.63e-05	197	137	8	490_DN
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; HL60; HT_HG-U133A	DRD2 TCF7L2 ANK3 MED14 ETV1 NR1D1 LRP3 MUC1	2.72e-05	198	137	8	2164_DN
Drug	Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A	WHRN MAGI1 HNF1B DRD2 EPS8L1 HIVEP3 CLCA2 SLC4A5	2.72e-05	198	137	8	5053_UP
Drug	Thyroxine (L) [51-48-9]; Down 200; 5.2uM; PC3; HT_HG-U133A	TCF7L2 ATXN7L1 ETV1 PCNX2 PER3 KIFC3 MUC1 UTRN	2.82e-05	199	137	8	4069_DN
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	WHRN HDAC9 EPS8L1 ATF2 HIVEP3 SMG7 CLCA2 LRP3	2.93e-05	200	137	8	7156_UP
Disease	Colorectal Carcinoma	TCF7L2 ATP7B OTOP2 ETV1 ZMIZ1 ZEB2 HIVEP3 CYREN BCL11B TENM1 DCHS1 PRKD1 LZTS2 PZP LEF1 EP300	1.34e-07	702	134	16	C0009402
Disease	Malignant neoplasm of breast	XIRP1 ATP7B MED14 ZMIZ1 SIM1 ATF2 ZEB2 ARID1B PTPRC PER3 CLCA2 HEY1 WDCP TENM1 NFYC MROH7 LZTS2 LEF1 EP300	4.18e-07	1074	134	19	C0006142
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC MUC6	9.10e-07	5	134	3	DOID:3030 (is_marker_for)
Disease	common bile duct neoplasm (is_marker_for)	MUC1 MUC4 MUC5AC	5.04e-06	8	134	3	DOID:4608 (is_marker_for)
Disease	urate measurement, bone density	TCF7L2 WDR7 ETV1 PEX14 SIM1 TENM2 SNX19 PSMG3-AS1 FNDC1 BCL11B MAST4 UTRN SH3RF3	5.23e-06	619	134	13	EFO_0003923, EFO_0004531
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	TCF7L2 HIVEP1 SIM1 SNX19 HIVEP3 TRIM66 UBN1 MAFB SSH2 CAMTA1	6.79e-06	364	134	10	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	brain measurement, neuroimaging measurement	VWA5B2 PDXDC1 HDAC9 MAGI1 TCF7L2 ANK3 CCDC88C BCL11B MAST4 ATXN7 SSH2 SH3RF3	8.38e-06	550	134	12	EFO_0004346, EFO_0004464
Disease	cholangiocarcinoma (is_marker_for)	MUC5B MUC1 MUC4 MUC5AC MUC6	1.10e-05	64	134	5	DOID:4947 (is_marker_for)
Disease	pulse pressure measurement	HDAC9 CUX2 TCF7L2 WDR7 LCA5L FHOD3 CCDC6 ZNF831 MAST2 SNX19 HIVEP3 TRIM66 FNDC1 ARID1B ZFHX4 NFATC2 ATXN7 CREB3L2 NIN	1.79e-05	1392	134	19	EFO_0005763
Disease	testosterone measurement	MAGI1 CUX2 TCF12 SPEM3 ANK3 ESRRG ZMIZ1 WRAP53 SHROOM4 ARID1B BCL11B PER3 ZFHX4 SKOR2 MAFB LEF1 UTRN SDC1	1.95e-05	1275	134	18	EFO_0004908
Disease	spinocerebellar ataxia type 7 (implicated_via_orthology)	ATXN7L1 ATXN7	2.05e-05	2	134	2	DOID:0050958 (implicated_via_orthology)
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP1 HIVEP2 HIVEP3	2.53e-05	13	134	3	DOID:0050787 (implicated_via_orthology)
Disease	neuroimaging measurement	VWA5B2 PDXDC1 HDAC9 MAGI1 TCF7L2 ANK3 OTUD7B JPH1 CCDC88C BCL11B MAST4 SSH2 CAMTA1 RAPGEF2 SH3RF3 CRTC2	2.92e-05	1069	134	16	EFO_0004346
Disease	cortical thickness	VWA5B2 HDAC9 MAGI1 TCF7L2 MAST2 TENM2 ARID1B BCL11B MAST4 SMG7 UBN1 SETD5 SSH2 CAMTA1 SH3RF3 FOXC2	4.72e-05	1113	134	16	EFO_0004840
Disease	obesity (implicated_via_orthology)	TCF7L2 TCF12 ETV1 SIM1 ZFHX4 DCHS1 LEF1	5.93e-05	215	134	7	DOID:9970 (implicated_via_orthology)
Disease	otitis media (biomarker_via_orthology)	MUC1 MUC4 MUC5AC	5.94e-05	17	134	3	DOID:10754 (biomarker_via_orthology)
Disease	breast carcinoma	CUX2 TCF7L2 ARHGEF28 ARHGEF5 ESRRG TRIM31 PEX14 ZMIZ1 MAST2 OTUD7B HIVEP3 CCDC88C ARID1B ATXN7 MAFB	6.35e-05	1019	134	15	EFO_0000305
Disease	Neurodevelopmental Disorders	TCF7L2 KMT2E HIVEP3 ARID1B SETD5	6.76e-05	93	134	5	C1535926
Disease	bipolar disorder	WHRN HDAC9 DRD2 HIVEP2 ANK3 ZMIZ1 SNX19 OTUD7B BCL11B INSYN2B PRKD1	6.84e-05	577	134	11	MONDO_0004985
Disease	social interaction measurement	DRD2 TCF7L2 HIVEP1 SIM1 TENM2	7.11e-05	94	134	5	EFO_0009592
Disease	body fat percentage	TCF7L2 HIVEP1 SIM1 SNX19 HIVEP3 TRIM66 UBN1 MAFB SSH2 CAMTA1	8.19e-05	488	134	10	EFO_0007800
Disease	sitting height ratio	TCF7L2 ZMIZ1 ARID1B NFATC2	8.61e-05	51	134	4	EFO_0007118
Disease	dry eye syndrome (is_implicated_in)	MUC1 MUC5AC	1.22e-04	4	134	2	DOID:10140 (is_implicated_in)
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC1 MUC4 MUC5AC	1.74e-04	61	134	4	DOID:3587 (is_marker_for)
Disease	red blood cell density measurement	PDXDC1 TCF7L2 HIVEP1 CEBPA ESRRG MAST2 ZEB2 ARID1B BCL11B PTPRC SSH2 CAMTA1 MUC4	1.93e-04	880	134	13	EFO_0007978
Disease	body weight	PDXDC1 HNF1B CUX2 TCF7L2 HIVEP1 HIVEP2 ESRRG SIM1 OTUD7B TRIM66 BCL11B MAST4 NFATC2 MAFB PRKD1 MUC1	2.00e-04	1261	134	16	EFO_0004338
Disease	Abnormality of head or neck	TMEM94 ZMIZ1	2.03e-04	5	134	2	C4021817
Disease	hematocrit	HNF1B TCF7L2 HIVEP1 HIVEP2 CEBPA ESRRG GCGR SIM1 MAST2 MPRIP ARID1B BCL11B ANKRD17 SSH2	2.12e-04	1011	134	14	EFO_0004348
Disease	obsessive-compulsive disorder, Tourette syndrome	WDR7 NFATC2 CAMTA1	2.21e-04	26	134	3	EFO_0004242, EFO_0004895
Disease	lymphocyte percentage of leukocytes	HDAC9 HIVEP1 CEBPA ZMIZ1 GMIP ZNF831 BCL11B PTPRC COQ8A HELZ MAFB	2.36e-04	665	134	11	EFO_0007993
Disease	obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa	DRD2 TCF7L2 GMIP TENM2 SNX19 BCL11B	3.15e-04	200	134	6	EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Disease	Myopia	TCF7L2 PSMG3-AS1 HIVEP3 ARID1B UBN1 RAPGEF2 PZP SH3RF3	3.90e-04	385	134	8	HP_0000545
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	4.24e-04	7	134	2	DOID:0050625 (is_marker_for)
Disease	Spinocerebellar Ataxia Type 2	ATXN1L CCDC88C ATXN7	4.94e-04	34	134	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	ATXN1L CCDC88C ATXN7	4.94e-04	34	134	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	ATXN1L CCDC88C ATXN7	4.94e-04	34	134	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	ATXN1L CCDC88C ATXN7	4.94e-04	34	134	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	ATXN1L CCDC88C ATXN7	4.94e-04	34	134	3	C0752124
Disease	Ataxia, Spinocerebellar	ATXN1L CCDC88C ATXN7	4.94e-04	34	134	3	C0087012
Disease	eye colour measurement	HDAC9 DRD2 ESRRG SIM1 ARID1B SKOR2	4.97e-04	218	134	6	EFO_0009764
Disease	hair colour measurement	HDAC9 CUX2 ATXN7L1 ETV1 PEX14 ZMIZ1 ZNF831 BCL11B MAFB LEF1	5.20e-04	615	134	10	EFO_0007822
Disease	Spinocerebellar Ataxia Type 4	ATXN1L CCDC88C ATXN7	5.39e-04	35	134	3	C0752122
Disease	triacylglycerol 58:6 measurement	TENM2 HIVEP3	5.63e-04	8	134	2	EFO_0010440
Disease	lung adenocarcinoma (is_marker_for)	WRAP53 MUC1 MUC4 SDC1	6.19e-04	85	134	4	DOID:3910 (is_marker_for)
Disease	BMI-adjusted waist circumference, forced expiratory volume	CUX2 OTUD7B	7.22e-04	9	134	2	EFO_0004314, EFO_0007789
Disease	manic episode measurement, depressive episode measurement	WHRN NFYC	7.22e-04	9	134	2	EFO_0007704, EFO_0007705
Disease	prostate cancer (is_marker_for)	KMT2E SETD5 MUC1 LEF1 EP300	7.48e-04	156	134	5	DOID:10283 (is_marker_for)
Disease	lysophosphatidylcholine 20:3 measurement	PDXDC1 NFATC2 PRKD1	8.00e-04	40	134	3	EFO_0010362
Disease	alopecia	HDAC9 TCF7L2 TCF12 PEX14 ZC3H12B PRKD1	8.39e-04	241	134	6	MONDO_0004907
Disease	hippocampal CA4 volume	PKD1L1 GMIP MAST4	8.60e-04	41	134	3	EFO_0009396
Disease	proteinuria (biomarker_via_orthology)	ZEB2 SDC1	8.99e-04	10	134	2	DOID:576 (biomarker_via_orthology)
Disease	dry eye syndrome (is_marker_for)	MUC1 MUC5AC	8.99e-04	10	134	2	DOID:10140 (is_marker_for)
Disease	otitis media (is_marker_for)	MUC5B MUC4	8.99e-04	10	134	2	DOID:10754 (is_marker_for)
Disease	allergic conjunctivitis (is_marker_for)	MUC1 MUC4	8.99e-04	10	134	2	DOID:11204 (is_marker_for)
Disease	allergic rhinitis (biomarker_via_orthology)	MUC1 MUC5AC	8.99e-04	10	134	2	DOID:4481 (biomarker_via_orthology)
Disease	Abnormality of refraction	TCF7L2 ANK3 ESRRG PKD1L1 PEX14 HIVEP3 PZP UTRN CREB3L2 NIN	1.03e-03	673	134	10	HP_0000539
Disease	schizophrenia, intelligence, self reported educational attainment	PDXDC1 DRD2 TCF7L2 KMT2E SNX19 ZEB2 PRKD1	1.06e-03	346	134	7	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	schizophrenia (is_marker_for)	DRD2 ANK3 ATF2	1.06e-03	44	134	3	DOID:5419 (is_marker_for)
Disease	coronary artery disease	HDAC9 CUX2 TCF7L2 HIVEP2 SRRM4 ETV1 ZNF831 ZEB2 OTUD7B FNDC1 MAST4 MAFB RAPGEF2 MUC1	1.09e-03	1194	134	14	EFO_0001645
Disease	pulmonary fibrosis	MUC5B MUC5AC	1.10e-03	11	134	2	EFO_0009448
Disease	Drugs used in diabetes use measurement	HNF1B TCF7L2 HIVEP2 ZMIZ1 NFATC2 ATXN7	1.12e-03	255	134	6	EFO_0009924
Disease	type 2 diabetes mellitus (is_implicated_in)	HNF1B DRD2 TCF7L2 GCGR FOXC2	1.13e-03	171	134	5	DOID:9352 (is_implicated_in)
Disease	pancreatic cancer (is_marker_for)	MUC1 MUC4 MUC5AC MUC6	1.18e-03	101	134	4	DOID:1793 (is_marker_for)
Disease	chronic obstructive pulmonary disease	HDAC9 TCF7L2 HIVEP2 ARHGEF28 ESRRG TRIM31 OTUD7B BCL11B MAFB SSH2	1.22e-03	688	134	10	EFO_0000341
Disease	rheumatic heart disease (biomarker_via_orthology)	ZEB2 LEF1	1.31e-03	12	134	2	DOID:0050827 (biomarker_via_orthology)
Disease	Antihypertensive use measurement	HDAC9 TCF7L2 HIVEP2 ZNF831 NFATC2 LEF1	1.37e-03	265	134	6	EFO_0009927
Disease	cholangiocarcinoma (biomarker_via_orthology)	MUC1 MUC4	1.55e-03	13	134	2	DOID:4947 (biomarker_via_orthology)
Disease	Bipolar Disorder	WHRN MAGI1 CUX2 DRD2 TCF7L2 ANK3 NR1D1 PER3	1.56e-03	477	134	8	C0005586
Disease	neutrophil count	MAGI1 CUX2 HIVEP1 HIVEP2 ZMIZ1 KMT2E MAST2 OTUD7B HIVEP3 BCL11B PTPRC COQ8A ATXN7 MAFB SSH2	1.56e-03	1382	134	15	EFO_0004833
Disease	Colorectal Neoplasms	TCF7L2 ATP7B ETV1 ZMIZ1 PRKD1 EP300	1.71e-03	277	134	6	C0009404
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	1.80e-03	14	134	2	DOID:10808 (implicated_via_orthology)
Disease	age at first sexual intercourse measurement	PDXDC1 TCF7L2 TENM2 SKOR2 PRKD1 CAMTA1 UTRN	1.88e-03	383	134	7	EFO_0009749
Disease	neutrophil percentage of leukocytes	HDAC9 HIVEP1 CEBPA ZMIZ1 GMIP ZNF831 COQ8A HELZ MAFB	1.93e-03	610	134	9	EFO_0007990
Disease	alcohol use disorder (implicated_via_orthology)	DRD2 EPS8L1 ARID1B SSH2 EP300	2.01e-03	195	134	5	DOID:1574 (implicated_via_orthology)
Disease	adult onset asthma	HDAC9 CEBPA PTPRC MUC5AC	2.09e-03	118	134	4	EFO_1002011
Disease	Alzheimer's disease (implicated_via_orthology)	HIVEP1 HIVEP2 HIVEP3	2.24e-03	57	134	3	DOID:10652 (implicated_via_orthology)
Disease	colorectal health	XIRP1 ESRRG PKD1L1 CBLB PCNX2	2.29e-03	201	134	5	EFO_0008460
Disease	asthma	HDAC9 MAGI1 HIVEP1 HIVEP2 CEBPA PEX14 PTPRC NFATC2 MROH7 MUC5AC	2.31e-03	751	134	10	MONDO_0004979
Disease	Cardiovascular Abnormalities	ZMIZ1 FOXC2	2.36e-03	16	134	2	C0243050
Disease	Seasonal Affective Disorder	NR1D1 PER3	2.36e-03	16	134	2	C0085159
Disease	brain connectivity measurement	MAGI1 MAST2 CCDC88C BCL11B SSH2 SH3RF3 FOXC2	2.40e-03	400	134	7	EFO_0005210
Disease	platelet component distribution width	HDAC9 HIVEP2 ZMIZ1 ZNF831 DCAF5 MPRIP TLK1 PTPRC MAFB CAMTA1	2.40e-03	755	134	10	EFO_0007984
Disease	mean platelet volume	HDAC9 HIVEP2 TCF12 ZMIZ1 DCAF5 MPRIP TLK1 PTPRC MAST4 UBN1 CAMTA1 NIN	2.42e-03	1020	134	12	EFO_0004584
Disease	loneliness measurement	HDAC9 TCF7L2 HIVEP1 UTRN	2.50e-03	124	134	4	EFO_0007865
Disease	risk-taking behaviour	TCF7L2 HIVEP1 ESRRG CCDC6 KMT2E TENM2 HIVEP3 ARID1B BCL11B EP300	2.62e-03	764	134	10	EFO_0008579
Disease	MAJOR AFFECTIVE DISORDER 2	MAGI1 CUX2	2.66e-03	17	134	2	C1839839
Disease	mood instability measurement	DRD2 TCF7L2 HIVEP2 EP300	2.81e-03	128	134	4	EFO_0008475
Disease	cystic fibrosis (is_marker_for)	MUC5B MUC1 MUC5AC	2.85e-03	62	134	3	DOID:1485 (is_marker_for)
Disease	hypertension, white matter hyperintensity measurement	CCDC88C BCL11B FOXC2	2.85e-03	62	134	3	EFO_0000537, EFO_0005665
Disease	Tinnitus	MAGI1 CBLB BCL11B NFATC2	2.97e-03	130	134	4	HP_0000360
Disease	hair color	ATXN7L1 ETV1 PEX14 ZMIZ1 ZNF831 LEF1	3.04e-03	311	134	6	EFO_0003924
Disease	response to vaccine, cytokine measurement	TENM2 CYREN TENM1 SLC4A5	3.05e-03	131	134	4	EFO_0004645, EFO_0004873
Disease	irritable bowel syndrome	TCF7L2 SIM1 SETD5 EP300	3.05e-03	131	134	4	EFO_0000555
Disease	eosinophil count	CUX2 HIVEP1 HIVEP2 CEBPA ATXN7L1 TRIM31 PEX14 GMIP CBLB HIVEP3 FNDC1 PTPRC NFATC2 MAFB MUC5AC	3.17e-03	1488	134	15	EFO_0004842
Disease	Breast Carcinoma	ATP7B SIM1 ZEB2 ARID1B PER3 HEY1 LEF1 EP300	3.26e-03	538	134	8	C0678222
Disease	cortical surface area measurement	HDAC9 MAGI1 TCF7L2 ANK3 MAST2 TENM2 MPRIP CCDC88C ARID1B BCL11B MAST4 PRKD1 SSH2 SH3RF3	3.27e-03	1345	134	14	EFO_0010736
Disease	diet measurement, HOMA-B	MAGI1 PCNX2	3.33e-03	19	134	2	EFO_0004469, EFO_0008111
Disease	balding measurement	HDAC9 TCF7L2 TCF12 PEX14 ZMIZ1 SIM1 PTPRC PRKD1 SDC1 NIN	3.38e-03	792	134	10	EFO_0007825
Disease	depressive symptom measurement	HDAC9 DRD2 TCF7L2 HIVEP1 TENM2 DCAF5 PRKD1	3.40e-03	426	134	7	EFO_0007006
Disease	diabetic retinopathy	TCF7L2 ARHGEF28 TENM2 MPRIP	3.49e-03	136	134	4	EFO_0003770

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSPVNNHHSPGQTPT	CEP170	1521	Q5SW79
SPHHVSPQTSSPHPG	EP300	2336	Q09472
TAPASRSHAAPSPGH	CDRT15L2	166	A8MXV6
QTGHSPHIHQTPSPS	CAMTA1	601	Q9Y6Y1
PHHGETISPHSSVGS	CATSPER1	241	Q8NEC5
TDHRSSSSHSPGSPP	ATP7B	336	P35670
LPSTPDSSHHAQATP	ARHGEF5	791	Q12774
HLPGSSNSPASAPHP	CCNJL	116	Q8IV13
HGAPRTASPPSALSH	LINC00528	71	Q8N1L1
TTHQDSPLPHPESTT	ATF2	131	P15336
AQSPFSPHASPHLSS	ARID1B	786	Q8NFD5
AATSQPTPSQHSAHP	CCDC6	456	Q16204
PPHGTTAPHKNSASV	ANKRD17	2181	O75179
HSHPDPTPQSPDSET	CUX2	1251	O14529
STSSNHSGHTPEPPL	ATXN7L1	411	Q9ULK2
PGSLTHSPPAAGQSH	ADNP2	316	Q6IQ32
TATTHGRSLPPSSPH	MUC5B	3451	Q9HC84
HSSTHEPNSTISPPS	MROH7	311	Q68CQ1
LSFSPAQSPPASHAH	PZP	566	P20742
PTSSPGAPNSARATH	NOBOX	216	O60393
ATLGHHQTPTPNSTG	OSBPL9	246	Q96SU4
HQTPTPNSTGSGHSP	OSBPL9	251	Q96SU4
SGHSPPSSSLTSPSH	OSBPL9	261	Q96SU4
SQHSSPLHVTAPPSA	KIAA1549	101	Q9HCM3
SDEHFSPGSHPSHIP	LEF1	161	Q9UJU2
SPGSHPSHIPSDVNS	LEF1	166	Q9UJU2
TESPTPHDSNSHRPQ	ARHGEF28	1656	Q8N1W1
PLPHSQESQHGSATS	LINC02906	46	E5RJ46
PHQDSIPSLEPGSHS	OTUD7B	741	Q6GQQ9
EHSPPCSVSPHTSSG	CYREN	91	Q9BWK5
TGHANPLHVTSPSSA	MUC4	3051	Q99102
QTPHTTHSPPTAGSP	MUC6	1401	Q6W4X9
SPQPSSHVAPQDHGS	NFATC2	276	Q13469
PPASHRSPISHEGSL	DCHS1	3231	Q96JQ0
SHPANPTCVTPHGTV	FAM189A1	216	O60320
PTHLINPSASHSDTP	PRKD1	881	Q15139
HVHPTTAPDVTSSLP	MPRIP	481	Q6WCQ1
HHQASPPPSSAASPA	MAFB	166	Q9Y5Q3
SHPGPGPHATASATA	MAFB	186	Q9Y5Q3
AEPTTSSPGGHLPSH	LZTS2	236	Q9BRK4
VPSPASSHHSSNQPA	MAGI1	936	Q96QZ7
HPHSSFPQASSPSSP	PSMG3-AS1	151	Q96PY0
ASDPGPDPQHHSTLE	GMIP	801	Q9P107
APSATSPSGQLPHHS	ATXN1L	201	P0C7T5
SPSGQLPHHSSTQPL	ATXN1L	206	P0C7T5
PEASPKHSHSPASSP	JPH1	466	Q9HDC5
PFSIPSHHSDTPTTL	MUC1	991	P15941
IPSSHPVSLNSQPSH	CBLB	711	Q13191
GSHTLQSPAPPSSHS	CCDC88C	1841	Q9P219
SLHASATSLHSQPPP	PCNX2	1986	A6NKB5
NPSHPTASALSTGSP	PER3	981	P56645
ASSTEGHPGAPSPQH	PDXDC1	746	Q6P996
SSTPVSPLHHASPNS	ETV1	141	P50549
NHAVGPSTSLPAGHS	TCF12	416	Q99081
SNHRASSSPGHGPPS	GCGR	431	P47871
ETPRTPSNGPGHEHS	DCAF5	736	Q96JK2
PPPSSVLASGHHTTS	KMT2E	1721	Q8IZD2
PHPQVSTASSTLGPH	LRP3	726	O75074
SHPLPPSQASTSHAF	LCA5L	631	O95447
TDHHPQTNPSVGTAA	GOLGA6L6	56	A8MZA4
HHPQTNPSVGTAASD	GOLGA6L22	21	H0YM25
STPAGSPDGSLPEHH	FOXC2	246	Q99958
THTPSNGPSSAHTGP	MUC5AC	1341	P98088
PAVPSPPSSTDHSSH	HELZ	1616	P42694
HSGPPYPSTVTSSHS	ATXN7	741	O15265
TSSLPTTHPPSHRAG	NFYC	346	Q13952
NPSLHSPVPDASHSP	MED14	1131	O60244
STPGHSHTPTPVSLF	OTOP2	271	Q7RTS6
ANHASGSPPATTPHR	NR1D1	316	P20393
GHSPADPAHVSHAPS	EEF1DP3	106	Q658K8
PAVAPIAASSHPHSS	BCL11B	151	Q9C0K0
HSDLTAPPNSPTGHH	FAM193B	241	Q96PV7
SSHLQSPPHAPSSAA	CEBPA	16	P49715
APGLHSPLSHPSLQS	CRTC2	331	Q53ET0
PQLQGSHSHPSLPAS	CRTC2	361	Q53ET0
GAPPSASASPAHHAS	FNDC1	611	Q4ZHG4
PASLTDSVNHHSPGG	ESRRG	46	P62508
VSASSPGTPHHPQAS	FHOD3	541	Q2V2M9
ANPPAPAASSTPHGH	CDC42EP1	271	Q00587
QSAPPSLGHAHSEGP	COQ8A	101	Q8NI60
TETHPQPHFSRTSSP	ANK3	1861	Q12955
HPSVSINPSVSVHPS	FLVCR2	36	Q9UPI3
INPSVSVHPSSSAHP	FLVCR2	41	Q9UPI3
SHSSSGHETLPPVLP	DUXB	201	A0A1W2PPF3
SPLHGHTGNSPLDSP	MAST2	191	Q6P0Q8
GPGSPTHSHSLSPRS	MAST2	1261	Q6P0Q8
PHSPLSAHAGNSPQD	MAST4	246	O15021
HGNAGTTASPTEPHH	HEY1	201	Q9Y5J3
DQSHGPSPEHTSPTP	CCDC174	426	Q6PII3
TLPDPSHHGLHSTPD	DRD2	306	P14416
SHHGLHSTPDSPAKP	DRD2	311	P14416
HHTSLDQSSPPLSGT	HDAC9	181	Q9UKV0
SSHPHVTLEGKPPNS	HDAC9	376	Q9UKV0
HHSQSPARSLNSTPP	EPS8L1	541	Q8TE68
LPQLSTSSGHGPAHT	S100PBP	116	Q96BU1
PSDHQGPPHTLVSHS	PRRT3	201	Q5FWE3
PISHFPTSPRSSHGL	PKD1L1	236	Q8TDX9
HLPPTPPSSHGSDSE	CREB3L2	201	Q70SY1
PCPSSDTHLPTHSGS	P2RX6	426	O15547
SHGSPHHQPSSSPPN	HNF1B	331	P35680
HHQPSSSPPNKLSGV	HNF1B	336	P35680
GSPPESIISPHHTSE	UTRN	3296	P46939
TSGPPNHHSSAPSHS	TRIM31	346	Q9BZY9
SDQDPAPAHPSPHAS	WRAP53	16	Q9BUR4
SGTSSQHLVPSPPKH	LRRC56	441	Q8IYG6
QHLRSTATPSPSPHA	NIN	1961	Q8N4C6
TPQPSARAHSAPSSG	KIFC3	796	Q9BVG8
PASSDHSTPASQSPH	SMG7	991	Q92540
HSTPASQSPHSSNPS	SMG7	996	Q92540
DISPHQTAGDHPTVS	SIM1	681	P81133
HSDLAPHPSLGPTSE	SETD5	941	Q9C0A6
SQSSPPHGEADGHPS	SHROOM4	491	Q9ULL8
HHETSTPAGPSQADL	SDC1	161	P18827
TPAGPSQADLHTPHT	SDC1	166	P18827
APAPPTSTQDSVHLH	TENM1	231	Q9UKZ4
SSGPPNHHSQSTLRP	TENM2	236	Q9NT68
PPVSCSPLGQHHDTT	SPATA31D4	101	Q6ZUB0
PSPSGHPDQTGTNQH	WHRN	706	Q9P202
HTPHSASDLTVSPDP	SSC5D	1426	A1L4H1
KSPSPSSPAAVNHHS	PEX14	246	O75381
NVPSTGHPATSAPHT	RITA1	206	Q96K30
GHPATSAPHTNGPQD	RITA1	211	Q96K30
VNHSPSISTPAHSIP	CLCA2	691	Q9UQC9
GPSSVQQPHGHPTSS	RAPGEF2	1446	Q9Y4G8
PKSPTHASPQHTQTE	UHRF1BP1L	416	A0JNW5
PAIRSPQNSHSHSTP	TLK1	166	Q9UKI8
PPVSCSPLGQHHDTT	SPATA31D3	101	P0C874
ATPHQHGFTPSTPGT	ZFHX4	586	Q86UP3
SPHPQHIYSSGSSPG	ZC3H6	466	P61129
SSSPEHNRPTDHPTS	SSH2	1081	Q76I76
HNRPTDHPTSILSSP	SSH2	1086	Q76I76
AHTSAPTPAQTPAHI	SPEM3	266	A0A1B0GUW6
HSPEHTSAHSPAQAP	SPEM3	321	A0A1B0GUW6
EIPPSSPSHAGSLHD	TMEM94	891	Q12767
QAHAQHPTASPPTGS	SH3RF3	576	Q8TEJ3
GHSASHDKDLTPPPS	SRRM4	91	A7MD48
SLHSHSSLAGTQPQP	TCF7L2	596	Q9NQB0
PHPALSHGTAPGSEA	HIVEP3	1516	Q5T1R4
QTLPTSPAGAHGPHS	VWCE	811	Q96DN2
SPARSPGAGPSLHHS	SLC4A5	241	Q9BY07
PTTPSSSDEHSPHNG	TMEM201	551	Q5SNT2
TAPHPAVHSPSAEVT	SNX19	196	Q92543
SSPVPGSSHFPHQKA	ZC3H12B	491	Q5HYM0
SSSPGSPVHHPSLEE	SKOR2	851	Q2VWA4
RHNSFTSPSPPGAHH	nan	96	Q6ZRN7
GTPPASHSHLDAAPL	VWA5B2	966	Q8N398
PASSSSALSHPAKPH	UBN1	876	Q9NPG3
HLEIPASGPSSASSH	ZNF831	1566	Q5JPB2
SPASVPNHESSPHVS	ZEB2	61	O60315
PASLPRHSSTPDHTS	WDCP	521	Q9H6R7
SSLPHSPCQSPSHPE	PRR30	136	Q53SZ7
PSHPEELHSSTLTSP	PRR30	146	Q53SZ7
PSSHHSSPGYDSSPC	HIVEP2	2041	P31629
QHLASSQHESPPGPA	TRIM66	486	O15016
TPHLPTHADSQTPSA	PTPRC	106	P08575
ADHSGSDPPSAPALH	WDR7	961	Q9Y4E6
PSGHSQPSLQHGLST	XIRP1	1391	Q702N8
NIAPDSHLSPVHPTS	HIVEP1	1436	P15822
AAPSSHPHSDLTFNP	ZMIZ1	996	Q9ULJ6
SPPPHFPHAATSSSA	UBALD1	106	Q8TB05
PRTHSSPSQGSHSQP	INSYN2B	306	A6NMK8
SPSQGSHSQPAHPGR	INSYN2B	311	A6NMK8
AFQTHPASTHTTPSP	MUC12	1136	Q9UKN1
QTHPASTHTTPSPPS	MUC12	2221	Q9UKN1
AFQTHPASTHTTPSP	MUC12	3776	Q9UKN1